Anton;velentzis2017.pdf;How will transitioning from cytology to HPV testing change the balance between the benefits and harms of cervical cancer screening? Estimates of the impact on cervical cancer, treatment rates and adverse obstetric outcomes in Australia, a high vaccination coverage country;Louiza S Velentzis, Michael Caruana, Kate T Simms, Jie-Bin Lew, Ju-Fang Shi, Marion Saville, Megan A Smith, Sarah J Lord, Jeffrey Tan, Deborah Bateson, Michael Quinn, Karen Canfell;
Anton;Draisma2009.pdf;lead time and overdiagnosis in prostate-specific antigen screening importance of methods and context;Wong SS, Leong AP, Leong TY.;
Anton;Campos2016.pdf;cost-effectiveness of an hpv self-collection campaign in uganda comparing models for delivery of cervical cancer screening in a low-income setting;Mandelblatt JS, Lawrence WF, Womack SM, Jacobson D, Yi B, Hwang YT, Gold K, Barter J, Shah K.;
Anton;montz2001.pdf;impact of increasing papanicolaou test sensitivity and compliance a modeled cost and outcomes analysis;Manuel MR, Chen LM, Caughey AB, Subak LL.;
Anton;hsieh2002.pdf;assessing chronic disease progression using non-homogeneous exponential regression markov models an illustration using a selective breast cancer screening in taiwan;Haug, U  Brenner, H;
Anton;feuer2002.pdf;modeling the impact of the decline in distant stage disease on prostate carcinoma mortality rates;;
Anton;draisma2003.pdf;lead times and overdetection due to prostate-specific antigen screening estimates from the european randomized study of screening for prostate cancer;Wu, Grace Hui-Min  Wang, Yi-Ming  Yen, Amy Ming-Fang  Wong, Jau-Min  Lai, Hsin-Chih  Warwick, Jane  Chen, Tony Hsiu-Hsi;
Anton;yen2003.pdf;quantifying the potential problem of overdiagnosis of ductal carcinoma in situ in breast cancer screening;Vijayaraghavan, Arthi  Efrusy, Molly  Lindeque, Gerhard  Dreyer, Greta  Santas, Christopher;
Anton;goldie2004.pdf;projected clinical benefits and cost-effectiveness of a human papillomavirus 1618 vaccine;Leshno M, Halpern Z, Arber N.;
Anton;pinsky2004.pdf;An Early- and Late-Stage Convolution Model for Disease Natural History;Plevritis S.K., Salzman P., Sigal B.M., Glynn P.W.;
Anton;barratt2005.pdf;model of outcomes of screening mammography information to support informed choices;Manser, R  Dalton, A  Carter, R  Byrnes, G  Elwood, M  Campbell, DA;
Anton;manser2005.pdf;cost-effectiveness analysis of screening for lung cancer with low dose spiral ct computed tomography in the australian setting;Lansdorp-Vogelaar, Iris  van Ballegooijen, Marjolein  Zauber, Ann G.  Boer, Rob  Wischut, Janneke  Habbema, J. Dik F.;
Anton;haug2005.pdf;a simulation model for colorectal cancer screening potential of stool tests with various performance characteristics compared with screening colonoscopy;Berg B., Denton B., Nelson H., Balasubramanian H., Rahman A., Bailey A., Lindor K.;
Anton;siebert2005.pdf;the german cervical cancer screening model development and validation of a decision-analytic model for cervical cancer screening in germany;Torvinen S, Nieminen P, Lehtinen M, Paavonen J, Demarteau N, Hahl J.;
Anton;groenewoud2006.pdf;cost-effectiveness of different reading and referral strategies in mammography screening in the netherlands;Weedon-Fekjaer, Harald  Lindqvist, Bo H.  Vatten, Lars J.  Aalen, Odd O.  Tretli, Steinar;
Anton;plevritis2006.pdf;a natural history model of stage progression applied to breast cancer;Anonychuk AM, Bauch CT, Merid MF, Van Kriekinge G, Demarteau N.;
Anton;stout2006.pdf;retrospective cost-effectiveness analysis of screening mammography;Diaz M, de Sanjose S, Ortendahl J, O'Shea M, Goldie SJ, Bosch FX, Kim JJ.;
Anton;blanks2008.pdf;the development of the referral outcome diagram and an analysis of laboratory cancer detection rates in the english nhs cervical screening programme--is there an optimum level of detection of cin 1 and cin 2 lesions;Kim, JJ  Leung, GM  Woo, PPS  Goldie, SJ;
Anton;weedonfekjr2008.pdf;breast cancer tumor growth estimated through mammography screening data;McMahon PM, Kong CY, Weinstein MC, Tramontano AC, Cipriano LE, Johnson BE, Weeks JC, Gazelle GS.;
Anton;bergeron2008.pdf;cost-effectiveness analysis of the introduction of a quadrivalent human papillomavirus vaccine in france;Armero, Carmen, Lopez-Quilez, Antonio, Lopez-Sanchez, Rut;
Anton;mcmahon2008.pdf;Adopting Helical CT Screening for Lung Cancer Potential Health Consequences During a 15-Year Period;Caleffi M, Ribeiro RA, Duarte Filho DL, Ashton-Prolla P, Bedin AJ Jr, Skonieski GP, Zignani JM, Giacomazzi J, Franco LR, Graudenz M, Pohlmann P, Fernandes JG, Kivitz P, Weber B.;
Anton;reynalesshigematsu2009.pdf;cost-effectiveness analysis of a quadrivalent human papilloma virus vaccine in mexico;Hsieh, HJ  Chen, THH  Chang, SH;
Anton;anonychuk2009.pdf;a cost-utility analysis of cervical cancer vaccination in preadolescent canadian females;Carter KJ, Castro F, Kessler E, Erickson B.;
Anton;vijayaraghavan2009.pdf;cost-effectiveness of high-risk hpv dna testing for cervical cancer screening in south africa;Arveux P, Wait S, Schaffer P.;
Anton;goldwasser2009.pdf;modeling excess lung cancer risk among screened arm participants in the mayo lung project;Berchi, C, Bouvier, V, Reaud, JM, Launoy, G;
Anton;yen2009.pdf;estimating the long-term clinical impact of cervical cancer vaccination in taiwan;;
Anton;berg2009.pdf;a discrete event simulation model to evaluate operational performance of a colonoscopy suite;Kulasingam S, Connelly L, Conway E, Hocking JS, Myers E, Regan DG, Roder D, Ross J, Wain G.;
Anton;wever2010.pdf;prostate-specific antigen screening in the united states vs in the european randomized study of screening for prostate cancer-rotterdam;Andres-Gamboa, Oscar  Chicaiza, Liliana  Garcia-Molina, Mario  Diaz, Jorge  Gonzalez, Mauricio  Murillo, Raul  Ballesteros, Monica  Sanchez, Ricardo;
Anton;berkhof2010.pdf;the health and economic effects of hpv dna screening in the netherlands;Rogoza RM, Westra TA, Ferko N, Tamminga JJ, Drummond MF, Daemen T, Wilschut JC, Postma MJ.;
Anton;jit2011.pdf;human papillomavirus vaccine introduction in low-income and middle-income countries guidance on the use of cost-effectiveness models;Bech M., Gyrd-Hansen D.;
Anton;chen2011.pdf;cost-effectiveness analysis for pap smear screening and human papillomavirus dna testing and vaccination;Ladabaum U, Chopra CL, Huang G, Scheiman JM, Chernew ME, Fendrick AM.;
Anton;goldie2011.pdf;model-based analyses to compare health and economic outcomes of cancer control inclusion of disparities;Bergeron C, Largeron N, McAllister R, Mathevet P, Remy V.;
Anton;draisma2013.pdf;a note on the catch-up time method for estimating lead or sojourn time in prostate cancer screening;PLoS One.  Aug .():e. doi: ./journal.pone.. Print .;
Anton;edwards2010.pdf;annual report to the nation on the status of cancer 1975-2006 featuring colorectal cancer trends and impact of interventions risk factors screening and treatment to reduce future rates;Costantino C, Calamusa G, Cusimano R, Firenze A, Romano N, Trecca A, Vitale F.;
Anton;dhar2018.pdf;Catalyzing Novel Approaches to Rapid, Accurate, and Affordable Early Cancer Detection;Chen P.-F., Chen C.-S., Chen C.-C., Lung F.-W.;
Anton;meza2014.pdf;comparative analysis of 5 lung cancer natural history and screening models that reproduce outcomes of the nlst and plco trials;Chiu, Sherry Y-H, Malila, Nea, Yen, Amy M-F, Anttila, Ahti, Hakama, Matti, Chen, H-H;
Anton;ladabaum2010.pdf;cost-effectiveness of colorectal cancer screening in high-risk spanish patients use of a validated model to inform public policy;Vacek PM, Skelly JM, Geller BM.;
Anton;silvaillanes2018.pdf;critical analysis of markov models used for the economic evaluation of colorectal cancer screening a systematic review;van Ballegooijen, Marjolein, Rutter, Carolyn M., Knudsen, Amy B., Zauber, Ann G., Savarino, James E., Lansdorp-Vogelaar, Iris, Boer, Rob, Feuer, Eric J., Habbema, J. Dik F., Kuntz, Karen M.;
Anton;gunsoy2014.pdf;estimating breast cancer mortality reduction and overdiagnosis due to screening for different strategies in the united kingdom;van Rossum, Leo G. M.  van Rijn, Anne F.  Verbeek, Andre L. M.  van Oijen, Martijn G. H.  Laheij, Robert J. F.  Fockens, Paul  Jansen, Jan B. M. J.  Adang, Eddy M. M.  Dekker, Evelien;
Anton;westra2013.pdf;Inclusion of the benefits of enhanced cross protection against cervical cancer and prevention of genital warts in the cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands;Chen, Meng-Kan  Hung, Hui-Fang  Duffy, Stephen  Yen, Amy Ming-Fang  Chen, Hsiu-Hsi;
Anton;Steen2015.pdf;Optimal Colorectal Cancer Screening in States? Low-Income, Uninsured Populations The Case of South Carolina;"Alex van der Steen, Amy B. Knudsen, Frank van Hees,
Gailya P. Walter, Franklin G. Berger, Virginie G. Daguise,
Karen M. Kuntz, Ann G. Zauber, Marjolein van Ballegooijen,
and Iris Lansdorp-Vogelaar";
Anton;kobayashi2007.pdf;prostate cancer screening strategies with re-screening interval determined by individual baseline prostate-specific antigen values are cost-effective;McMahon, Pamela M., Kong, Chung Yin, Bouzan, Colleen, Weinstein, Milton C., Cipriano, Lauren E., Tramontano, Angela C., Johnson, Bruce E., Weeks, Jane C., Gazelle, G. Scott;
Anton;10.1002@ijc.31265.pdf;Quality of life assumptions determine which cervical cancer screening strategies are cost-effective;Carles M, Vilaprinyo E, Cots F, Gregori A, Pla R, Rom?n R, Sala M, Maci? F, Castells X, Rue M.;
Anton;uuskla2013.pdf;The epidemiological and economic impact of aqua-drivalent human papillomavirus (hpv) vaccine in Estonia;Sroczynski G., Schnell-Inderst P., Muhlberger N., Lang K., Aidelsburger P., Wasem J., Mittendorf T., Engel J., Hillemanns P., Petry K.U., Kramer A., Siebert U.;
Anton;nihms115777.pdf;trade-offs in cervical cancer prevention balancing benefits and risks;Quentin W, Adu-Sarkodie Y, Terris-Prestholt F, Legood R, Opoku BK, Mayaud P.;
Anton;rutter2017.pdf;Effect of Time to Diagnostic Testing for Breast, Cervical, and Colorectal Cancer Screening Abnormalities on Screening Efficacy: A Modeling Study;de Gelder, Rianne, Fracheboud, Jacques, Heijnsdijk, Eveline A. M., den Heeten, Gerard, Verbeek, Andre L. M., Broeders, Mireille J. M., Draisma, Gerrit, de Koning, Harry J.;
Anton;gulati2012.pdf;the impact of plco control arm contamination on perceived psa screening efficacy;JAMA.  Oct .():-.;
Anton;schultz2012.pdf;chapter 7 description of miscan-lung the erasmus mc lung cancer microsimulation model for evaluating cancer control interventions;Pinsky PF.;
Anton;hanly2012.pdf;cost-effectiveness of computed tomography colonography in colorectal cancer screening a systematic review;Okonkwo, Quirine Lamberts  Draisma, Gerrit  der Kinderen, Arno  Brown, Martin L.  de Koning, Harry J.;
Anton;gunsoy2012.pdf;Modelling the overdiagnosis of breast cancer due to mammography screening in women aged 40to 49 in the United Kingdom;Annemans L., Remy V., Oyee J., Largeron N.;
Anton;luttjeboer2013.pdf;cost-effectiveness of the prophylactic hpv vaccine an application to the netherlands taking non-cervical cancers and cross-protection into account;Schultz FW, Boer R, de Koning HJ.;
Anton;quentin2011.pdf;costs of cervical cancer screening and treatment using visual inspection with acetic acid via and cryotherapy in ghana the importance of scale;McMahon PM, Kong CY, Johnson BE, Weinstein MC, Weeks JC, Tramontano AC, Cipriano LE, Bouzan C, Gazelle GS.;
Anton;vanagas2012.pdf;healthcare spending in the case of a hpv1618 population-wide vaccination programme;Lin, Ray S., Plevritis, Sylvia K.;
Anton;crowcroft2012.pdf;Human papilloma virus vaccination programs reduce health inequity in most scenarios: a simulation study;Lansdorp-Vogelaar, Iris  Kuntz, Karen M.  Knudsen, Amy B.  van Ballegooijen, Marjolein  Zauber, Ann G.  Jemal, Ahmedin;
Anton;uhry2010.pdf;multi-state markov models in cancer screening evaluation a brief review and case study;Lucidarme O, Cadi M, Berger G, Taieb J, Poynard T, Grenier P, Beresniak A.;
Anton;navernik2014.pdf;output correlations in probabilistic models with multiple alternatives;Voko, Zoltan  Nagyjanosi, Laszlo  Kalo, Zoltan;
Anton;zelle2014.pdf;predicting the stage shift as a result of breast cancer screening in low- and middle-income countries a proof of concept;Burger, E. A.  Ortendahl, J. D.  Sy, S.  Kristiansen, I. S.  Kim, J. J.;
Anton;armstrong2010.pdf;prophylaxis of cervical cancer and related cervical disease a review of the cost-effectiveness of vaccination against oncogenic hpv types;Hanly, Paul  Skally, Mairead  Fenlon, Helen  Sharp, Linda;
Anton;wever2012.pdf;to be screened or not to be screened modeling the consequences of psa screening for the individual;Zelle SG, Nyarko KM, Bosu WK, Aikins M, Ni??ns LM, Lauer JA, Sepulveda CR, Hontelez JA, Baltussen R.;
Anton;yeh2013.pdf;sorting it out pile sorting as a mixed methodology for exploring barriers to cancer screening;Wong IO, Kuntz KM, Cowling BJ, Lam CL, Leung GM.;
Anton;petry2013.pdf;Annual Papanicolaou screening for 5 years among human papillomavirus-negative women;Wu D, Erwin D, Rosner GL.;
Anton;witte2017.pdf;an em algorithm for nonparametric estimation of the cumulative incidence function from repeated imperfect test results;Draisma, Gerrit  van Rosmalen, Joost;
Anton;10.1093@jnci@djv103.pdf;benefits and harms of mammography screening after age 74 years model estimates of overdiagnosis;Stollenwerk, Bjoern  Gandjour, Afschin  Luengen, Markus  Siebert, Uwe;
Anton;ekwunife2016.pdf;challenges in cost-effectiveness analysis modelling of hpv vaccines in low- and middle-income countries a systematic review and practice recommendations;Arrospide A, Forn?? C, Ru?? M, Tor? N, Mar J, Bar?? M.;
Anton;10.1002@cncr.31141.pdf;comparative effectiveness of prostate cancer screening between the ages of 55 and 69 years followed by active surveillance;Petry, Karl Ulrich  Rinnau, Franziska  Boehmer, Gerd  Hollwitz, Bettina  Luyten, Alexander  Buttmann, Nina  Bruenger, Martin  Iftner, Thomas;
Anton;wu2006.pdf;cost-effectiveness analysis of colorectal cancer screening with stool dna testing in intermediate-incidence countries;Steens A, Wielders CC, Bogaards JA, Boshuizen HC, de Greeff SC, de Melker HE.;
Anton;vok2012.pdf;cost-effectiveness of adding vaccination with the AS04-adjuvanted human papillomavirus 16/18 vaccine to cervical cancer screening in Hungary;Hsieh, Jeff Ching-Fu  Cramb, Susanna M.  McGree, James M.  Baade, Peter D.  Dunn, Nathan A. M.  Mengersen, Kerrie L.;
Anton;romagnuolo2007.pdf;cost-effectiveness of Colorectal Cancer Screening With Computed Tomography Colonography The Impact of Not Reporting Diminutive Lesions;Timmers JM, Verbeek AL, IntHout J, Pijnappel RM, Broeders MJ, den Heeten GJ.;
Anton;chesson2008.pdf;cost-effectiveness of Human Papillomavirus Vaccination inthe United States;Saini S.D., Schoenfeld P., Vijan S.;
Anton;berkhof2006.pdf;evaluation of cervical screening strategies with adjunct high-risk human papillomavirus testing for women with borderline or mild dyskaryosis;Gulati, Roman  Gore, John L.  Etzioni, Ruth;
Anton;duffy2005.pdf;overdiagnosis and overtreatment of breast cancer - estimates of overdiagnosis from two trials of mammographic screening for breast cancer;Cronin, Paula, Goodall, Stephen, Lockett, Trevor, O'Keefe, Christine M., Norman, Richard, Church, Jody;
Anton;olsen2006.pdf;overdiagnosis sojourn time and sensitivity in the copenhagen mammography screening program;;
Anton;10.1177@0969141316629505.pdf;The role of pre-invasive disease in overdiagnosis: A microsimulation study comparing mass screening for breast cancer and cervical cancer;Luttjeboer J, Westra TA, Wilschut JC, Nijman HW, Daemen T, Postma MJ.;
Anton;jit2014.pdf;cost-effectiveness of female human papillomavirus vaccination in 179 countries a prime modelling study;;
Anton;huh2014.pdf;cost-effectiveness of human papillomavirus-16/18 genotyping in cervical cancer screening;Will BP, Berthelot JM, Nobrega KM, Flanagan W, Evans WK.;
Anton;duffy2014.pdf;translation of research results to simple estimates of the likely effect of a lung cancer screening programme in the united kingdom;Karnon, Jonathan, Jones, Roy, Czoski-Murray, Carolyn, Srnith, Kevin J.;
Anton;gulati2014.pdf;individualized estimates of overdiagnosis in screen-detected prostate cancer;Reynales-Shigematsu LM, Rodrigues ER, Lazcano-Ponce E.;
Anton;mcmahon2014.pdf;comparing benefits from many possible computed tomography lung cancer screening programs extrapolating from the national lung screening trial using comparative modeling;Edwards BK, Ward E, Kohler BA, Eheman C, Zauber AG, Anderson RN, Jemal A, Schymura MJ, Lansdorp-Vogelaar I, Seeff LC, van Ballegooijen M, Goede SL, Ries LA.;
Anton;lansdorpvogelaar2012.pdf;contribution of screening and survival differences to racial disparities in colorectal cancer rates;Zai, Adrian H., Kim, Seokjin, Kamis, Arnold, Hung, Ken, Ronquillo, Jeremiah G., Chueh, Henry C., Atlas, Steven J.;
Anton;neeser2007.pdf;cost-effectiveness analysis of a quality-controlled mammography screening program from the swiss statutory health-care perspective quantitative assessment of the most influential factors;Roso-Llorach, Albert  Forne, Caries  Macia, Francesc  Galceran, Jaume  Marcos-Gragera, Rafael  Rue, Montserrat;
Anton;ekwunife2017.pdf;cost-effectiveness of human papilloma virus hpv vaccination in nigeria a decision analysis using pragmatic parameter estimates for cost and programme coverage;Dolan JG, Boohaker E, Allison J, Imperiale TF.;
Anton;han2017 (1).pdf;evaluating the impact of varied compliance to lung cancer screening recommendations using a microsimulation model;Meza, Rafael  ten Haaf, Kevin  Kong, Chung Yin  Erdogan, Ayca  Black, William C.  Tammemagi, Martin C.  Choi, Sung Eun  Jeon, Jihyoun  Han, Summer S.  Munshi, Vidit  van Rosmalen, Joost  Pinsky, Paul  McMahon, Pamela M.  de Koning, Harry J.  Feuer, Eric J.  Hazelton, William D.  Plevritis, Sylvia K.;
Anton;mennini2009.pdf;health and economic impact associated with a quadrivalent hpv vaccine in italy;McMahon, Pamela M.  Meza, Rafael  Plevritis, Sylvia K.  Black, William C.  Tammemagi, C. Martin  Erdogan, Ayca  ten Haaf, Kevin  Hazelton, William  Holford, Theodore R.  Jeon, Jihyoun  Clarke, Lauren  Kong, Chung Yin  Choi, Sung Eun  Munshi, Vidit N.  Han, Summer S.  van Rosmalen, Joost  Pinsky, Paul F.  Moolgavkar, Suresh  de Koning, Harry J.  Feuer, Eric J.;
Anton;meester2017.pdf;Impact of Adenoma Detection on the Benefit of Faecal Testing versus Colonoscopy for Colorectal Cancer;Granados-Garcia V., Flores Y.N., Perez R., Rudolph S.E., Lazcano-Ponce E., Salmeron J.;
Anton;seigneurin2016.pdf;overdiagnosis and overtreatment associated with breast cancer mammography screening a simulation study with calibration to population-based data;Ahern CH, Shih YC, Dong W, Parmigiani G, Shen Y.;
Anton;seigneurin2015.pdf;overdiagnosis associated with breast cancer screening a simulation study to compare lead-time adjustment methods;Pataky, Reka  Ismail, Zahra  Coldman, Andrew J.  Elwood, Mark  Gelmon, Karen  Hedden, Lindsay  Hislop, Greg  Kan, Lisa  McCoy, Bonnie  Olivotto, Ivo A.  Peacock, Stuart;
Anton;lang2011.pdf;quality of life treatments and patients willingness to pay for a complete remission of cervical cancer in taiwan;Ouakrim, Driss A., Boussioutas, Alex, Lockett, Trevor, Hopper, John L., Jenkins, Mark A.;
Anton;jansen2013.pdf;quantifying lead-time bias in risk factor studies of cancer through simulation;Jit M, Brisson M, Portnoy A, Hutubessy R.;
Anton;campos2015.pdf;cervical cancer screening in low-resource settings a cost-effectiveness framework for valuing tradeoffs between test performance and program coverage;Zheng, L  Chan, AK;
Anton;levin2015.pdf;an extended cost-effectiveness analysis of publicly financed hpv vaccination to prevent cervical cancer in china;Goldie S.J., Kuntz K.M.;
Anton;sepp2015.pdf;age-related incidence of cervical cancer supports two aetiological components a population-based register study;Shen, Y  Parmigiani, G;
Anton;ruile2015.pdf;screening for breast cancer with breast-ct in a prohta simulation;Thiry N, De Laet C, Hulstaert F, Neyt M, Huybrechts M, Cleemput I.;
Anton;lansdorpvogelaar2015.pdf;state disparities in colorectal cancer rates contributions of risk factors screening and survival differences;Moore, Susan G.  Shenoy, Pareen J.  Fanucchi, Laura  Tumeh, John W.  Flowers, Christopher R.;
Anton;birnbaum2015.pdf;Projecting Benefits and Harms of Novel Cancer Screening Biomarkers: A Study of PCA3 and Prostate Cancer;Knudsen, Amy B.  Lansdorp-Vogelaar, Iris  Rutter, Carolyn M.  Savarino, James E.  van Ballegooijen, Marjolein  Kuntz, Karen M.  Zauber, Ann G.;
Anton;kolevakolarova2018.pdf;a modelling study to evaluate the costs and effects of lowering the starting age of population breast cancer screening;Guerrero AM, Genuino AJ, Santillan M, Praditsitthikorn N, Chantarastapornchit V, Teerawattananon Y, Alejandria M, Toral JA.;
Anton;mcleod2017.pdf;Colorectal cancer screening: How health gains and cost-effectiveness vary by ethnic group, the impact on health inequalities, and the optimal age-range to screen;Levin CE, Sharma M, Olson Z, Verguet S, Shi JF, Wang SM, Qiao YL, Jamison DT, Kim JJ.;
Anton;kafadar2005.pdf;computational methods in medical decision making to screen or not to screen;Khatibi M., Rasekh H.R.;
Anton;pataky2014 (1).pdf;cost-effectiveness of annual versus biennial screening mammography for women with high mammographic breast density;van Ravesteyn, Nicolien T.  Stout, Natasha K.  Schechter, Clyde B.  Heijnsdijk, Eveline A. M.  Alagoz, Oguzhan  Trentham-Dietz, Amy  Mandelblatt, Jeanne S.  de Koning, Harry J.;
Anton;10.1093@jnci@94.3.193.pdf;cost-effectiveness of cervical cancer screening comparison of screening policies;Sprague BL, Stout NK, Schechter C, van Ravesteyn NT, Cevik M, Alagoz O, Lee CI, van den Broek JJ, Miglioretti DL, Mandelblatt JS, de Koning HJ, Kerlikowske K, Lehman CD, Tosteson AN.;
Anton;10.2307@41995445.pdf;cost-effectiveness of high-risk human papillomavirus testing for cervical cancer screening in quebec canada;Cancer Prev Res (Phila).  Jun.():-. doi: ./-.CAPR--. Epub  Apr .;
Anton;rogoza2009.pdf;cost-effectiveness of prophylactic vaccination against human papillomavirus 1618 for the prevention of cervical cancer adaptation of an existing cohort model to the situation in the netherlands;Campos, Nicole G.  Castle, Philip E.  Wright, Thomas C., Jr.  Kim, Jane J.;
Anton;pickhardt2008.pdf;is there sufficient mdct capacity to provide colorectal cancer screening with ct colonography for the us population;Ko MJ, Kim J, Kim Y, Lee YJ, Hong SR, Lee JK.;
Anton;etzioni2002.pdf;overdiagnosis due to prostate-specific antigen screening lessons from us prostate cancer incidence trends;Gocgun Y, Banjevic D, Taghipour S, Montgomery N, Harvey BJ, Jardine AK, Miller AB.;
Anton;stoykova2008.pdf;putting national institute for health and clinical excellence guidance into practice a cost minimization model of a national roll-out of liquid based cytology in england;Sankatsing VD, Heijnsdijk EA, van Luijt PA, van Ravesteyn NT, Fracheboud J, de Koning HJ.;
Anton;myers2000.pdf;setting the target for a better cervical screening test characteristics of a cost-effective test for cervical neoplasia screening;Huh, Warner K.  Williams, Erin  Huang, Joice  Bramley, Tommy  Poulios, Nick;
Anton;luttjeboer2016.pdf;threshold cost-effectiveness analysis for a therapeutic vaccine against hpv-1618-positive cervical intraepithelial neoplasia in the netherlands;Med J Aust.  Feb .():-.;
Anton;silva2016.pdf;comparison of markov models used for the economic evaluation of colorectal cancer screening a systematic review;Borras, JM  Espinas, JA  Beemsterboer, PMM  Granados, A  de Koning, HJ;
Anton;ladabaum2016.pdf;Comparative Effectiveness and cost-effectiveness of a Multi-target Stool DNA Test to Screen for Colorectal Neoplasia;;
Anton;bertsimas2016.pdf;optimal healthcare decision making under multiple mathematical models application in prostate cancer screening;Sonnenberg, A, Delco, F;
Anton;smith2016.pdf;transitioning from cytology-based screening to hpv-based screening at longer intervals implications for resource use;Whynes, DK, Frew, EJ, Edwards, R, Atkin, WS;
Anton;carlsson2016.pdf;estimating the harms and benefits of prostate cancer screening as used in common practice versus recommended good practice a microsimulation screening analysis;Stone CA, Carter RC, Vos T, John JS.;
Anton;goldwasser2016.pdf;Estimation of the tumor size at cure threshold among aggressive non-small cell lung cancers (NSCLCs): Evidence from The Surveillance, Epidemiology, and End Results Program (SEER) and the National Lung Screening Trial (NLST).;Boer R, Plevritis S, Clarke L.;
Anton;liu2016.pdf;Effect of vaccination age on cost-effectiveness of human papillomavirus vaccination against cervical cancer in China;Ladabaum, U  Phillips, KA;
Anton;posso2016.pdf;cost-effectiveness of Double Reading versus Single Reading of Mammograms in a Breast Cancer Screening Programme;Roberts, Stephen, Wang, Lijun, Klein, Robert, Ness, Reid, Dittus, Robert;
Anton;felix2016.pdf;the clinical and economic benefits of co-testing versus primary hpv testing for cervical cancer screening a modeling analysis;de Gelder, Rianne  Bulliard, Jean-Luc  de Wolf, Chris  Fracheboud, Jacques  Draisma, Gerrit  Schopper, Doris  de Koning, Harry J.;
Anton;gogov2016.pdf;Methodological features of prostate cancer screening models ? A review of simulation models;Konno R, Sasagawa T, Fukuda T, Van Kriekinge G, Demarteau N.;
Anton;matthijsse2016.pdf;public health benefits of routine human papillomavirus vaccination for adults in the netherlands a mathematical modeling study;;
Anton;palma2015.pdf;a system dynamics model of serum prostate-specific antigen screening for prostate cancer;Akhavan-Tabatabaei R., Sanchez D.M., Yeung T.G.;
Anton;lansdorpvogelaar2009.pdf;at what costs will screening with ct colonography be competitive a cost-effectiveness approach;Palma, Anton  Lounsbury, David W.  Schlecht, Nicolas F.  Agalliu, Ilir;
Anton;saini2013.pdf;can the adenoma detection rate reliably identify low-performing endoscopists results of a modeling study;Seppa K., Pitkaniemi J., Malila N., Hakama M.;
Anton;landy2017.pdf;comparative effectiveness and cost-effectiveness of a multitarget stool dna test to screen for colorectal neoplasia;Lee CI,,, Lee JM,, Tosteson AN.;
Anton;munoz2018.pdf;estimating breast cancer survival by molecular subtype in the absence of screening and adjuvant treatment;Joseph, Djenaba A., Meester, Reinier G. S., Zauber, Ann G., Manninen, Diane L., Winges, Linda, Dong, Fred B., Peaker, Brandy, van Ballegooijen, Marjolein;
Anton;gray2017.pdf;evaluation of a stratified national breast screening program in the united kingdom an early model-based cost-effectiveness analysis;Gastroenterology.  Sep.():-.e. doi: ./j.gastro.... Epub  Jun .;
Anton;sasieni2009.pdf;how many cervical cancers are prevented by treatment of screen-detected disease in young women;Silva, N. S.;
Anton;pataky2014.pdf;is prostate cancer screening cost-effective a microsimulation model of prostate-specific antigen-based screening for british columbia canada;Cromwell I,, Gaudet M,, Peacock SJ,,, Aquino-Parsons C.;
Anton;demarteau2010.pdf;modelling the economic value of cross- and sustained-protection in vaccines against cervical cancer;Pil L, Fobelets M, Putman K, Trybou J, Annemans L.;
Anton;meester2015.pdf;public health impact of achieving 80 colorectal cancer screening rates in the united states by 2018;Nahvijou A, Daroudi R, Tahmasebi M, Amouzegar Hashemi F, Rezaei Hemami M, Akbari Sari A, Barati Marenani A, Zendehdel K.;
Anton;muhlberger2015.pdf;the oncotyrol prostate cancer outcome and policy model effect of prevalence assumptions on the benefit-harm balance of screening;Simms, Kate T.  Laprise, Jean-Francois  Smith, Megan A.  Lew, Jie-Bin  Caruana, Michael  Brisson, Marc  Canfell, Karen;
Anton;burger2014.pdf;the value of improving failures within a cervical cancer screening program an example from norway;Haghighat, Shahpar, Akbari, Mohammad Esmaeil, Yavari, Parvin, Javanbakht, Mehdi, Ghaffari, Shahram;
Anton;trenthamdietz2017.pdf;Comparative effectiveness of incorporating a hypothetical DCIS prognostic marker into breast cancer screening;Cancer.  Apr .():-. doi: ./cncr.. Epub  Feb .;
Anton;chiu2017.pdf;predicting the effectiveness of the finnish population-based colorectal cancer screening programme;van den Akker-van Marle, ME  van Ballegooijen, M  van Oortmarssen, GJ  Boer, R  Habbema, JDF;
Anton;andersson2017.pdf;assessment of lead-time bias in estimates of relative survival for breast cancer;Lejeune C, Arveux P, Dancourt V, Fagnani F, Bonithon-Kopp C, Faivre J.;
Anton;jacklyn2017.pdf;Impact of extending screening mammography to older women: information to support informed choices;Lejeune, C, Arveux, P, Dancourt, V, Bejean, S, Bonithon-Kopp, C, Faivre, J;
Anton;lew2017.pdf;Long-term evaluation of benefits, harms, and cost-effectiveness of the National Bowel Cancer Screening Program in Australia: a modelling study;Obradovic M, Mrhar A, Kos M.;
Anton;han2017.pdf;The impact of overdiagnosis on the selection of efficient lung cancer screening strategies;Lejeune C, Dancourt V, Arveux P, Bonithon-Kopp C, Faivre J.;
Anton;10.1109@42.932741.pdf;an artificial intelligent algorithm for tumor detection in screening mammogram;Maturitas.  Mar.:-. doi: ./j.maturitas.... Epub  Dec .;
Anton;nihms408197.pdf;chapter 9 the mgh-hms lung cancer policy model tobacco control versus screening;Witte BI, Berkhof J, Jonker MA,.;
Anton;szucs2008.pdf;cost-effectiveness analysis of adding a quadrivalent hpv vaccine to the cervical cancer screening programme in switzerland;Andersson TM, Rutherford MJ, Humphreys K.;
Anton;burger2012.pdf;cost-effectiveness of cervical cancer screening with primary human papillomavirus testing in norway;van Luijt PA, Heijnsdijk EA, van Ravesteyn NT, Hofvind S, de Koning HJ.;
Anton;10.1002@ijc.30513.pdf;cost-effectiveness of the Norwegian Breast cancer screening program.;Ekwunife OI,, O'Mahony JF, Gerber Grote A,, Mosch C, Paeck T, Lhachimi SK,.;
Anton;boer2004.pdf;Diversity of model approaches for breast cancer screening: a review of model assumptions by The Cancer Intervention and Surveillance Network(CISNET) Breast Cancer Groups;Prakash, Meher K., Lang, Brian, Heinrich, Henriette, Valli, Piero V., Bauerfeind, Peter, Sonnenberg, Amnon, Beerenwinkel, Niko, Misselwitz, Benjamin;
Anton;kohli2006.pdf;estimating the long-term impact of a prophylactic human papillomavirus 1618 vaccine on the burden of cervical cancer in the uk;McLeod M., Kvizhinadze G., Boyd M., Barendregt J., Sarfati D., Wilson N., Blakely T.;
Anton;geurts2015.pdf;likely effect of adding flexible sigmoidoscopy to the english nhs bowel cancer screening programme impact on colorectal cancer cases and deaths;;
Anton;etzioni2013.pdf;limitations of basing screening policies on screening trials the us preventive services task force and prostate cancer screening;Lich, Kristen Hassmiller, Cornejo, David A., Mayorga, Maria E., Pign Michael, Tangka, Florence K. L., Richardson, Lisa C., Kuo, Tzy-Mey, Meyer, Anne-Marie, Hall, Ingrid J., Smith, Judith Lee, Durham, Todd A., Chall, Steven A., Crutchfield, Trisha M., Wheeler, Stephanie B.;
Anton;10.1002@cncr.29952.pdf;nonbleeding adenomas evidence of systematic false-negative fecal immunochemical test results and their implications for screening effectiveness-a modeling study;Schiller-Fruethwirth, Irmgard C.  Jahn, Beate  Arvandi, Marjan  Siebert, Uwe;
Anton;10.1186@bcr1369.pdf;overdiagnosis and overtreatment of breast cancer microsimulation modelling estimates based on observed screen and clinical data;Campos, Nicole G.  Tsu, Vivien  Jeronimo, Jose  Njama-Meya, Denise  Mvundura, Mercy  Kim, Jane J.;
Anton;arnold2018.pdf;personalized mammography screening and screening adherence-a simulation and economic evaluation;Zimmermann, Marita R., Vodicka, Elisabeth, Babigumira, Joseph B., Okech, Timothy, Mugo, Nelly, Sakr, Samah, Garrison, Louis P., Chung, Michael H.;
Anton;nihms451467.pdf;response reading between the lines of cancer screening trials using modeling to understand the evidence;Ekwunife O.I., Lhachimi S.K.;
Anton;goldwasser2012.pdf;small median tumor diameter at cure threshold20 mm among aggressive non-small cell lung cancers in male smokers predicts both chest x-ray and ct screening outcomes in a novel simulation framework;Sharma M, Seoud M, Kim JJ.;
Anton;matthijsse2015.pdf;the role of acquired immunity in the spread of human papillomavirus hpv explorations with a microsimulation model;van Luijt, P. A.  Heijnsdijk, E. A. M.  de Koning, H. J.;
Anton;nihms331310.pdf;Long-term Projections of the Number Needed to Screen and Additional Number Needed to Treat in Prostate Cancer Screening;van der Meulen, Miriam P., Kapidzic, Atija, van Leerdam, Monique E., van der Steen, Alex, Kuipers, Ernst J., Spaander, Manon C. W., de Koning, Harry J., Hol, Lieke, Lansdorp-Vogelaar, Iris;
Anton;castle2018.pdf;inefficiencies of over-screening and under-screening for cervical cancer prevention in the us;Neeser, Kurt  Szucs, Thomas  Bulliard, Jean-Luc  Bachmann, Gaudenz  Schramm, Wendelin;
Anton;plevritis2018.pdf;association of screening and treatment with breast cancer mortality by molecular subtype in us women 2000-2012;Bailey, Stephanie L.  Sigal, Bronislava M.  Plevritis, Sylvia K.;
Anton;wolf2018.pdf;colorectal cancer screening for average-risk adults 2018 guideline update from the american cancer society;Rutter, Carolyn M., Savarino, James E.;
Anton;huang2017.pdf;a bayesian simulation model for breast cancer screening incidence treatment and mortality;Huang, Xuelin, Li, Yisheng, Song, Juhee, Berry, Donald A.;
Anton;konno2010.pdf;cost-effectiveness analysis of prophylactic cervical cancer vaccination in japanese women;Plevritis, Sylvia K.  Munoz, Diego  Kurian, Allison W.  Stout, Natasha K.  Alagoz, Oguzhan  Near, Aimee M.  Lee, Sandra J.  van den Broek, Jeroen J.  Huang, Xuelin  Schechter, Clyde B.  Sprague, Brian L.  Song, Juhee  de Koning, Harry J.  Trentham-Dietz, Amy  van Ravesteyn, Nicolien T.  Gangnon, Ronald  Chandler, Young  Li, Yisheng  Xu, Cong  Ergun, Mehmet Ali  Huang, Hui  Berry, Donald A.  Mandelblatt, Jeanne S.;
Anton;schillerfrhwirth2017.pdf;cost-effectiveness models in breast cancer screening in the general population a systematic review;Hsu, Chen-Yang, Yen, Ming-Fang, Auvinen, Anssi, Chiu, Yueh-Hsia, Chen, Hsiu-Hsi;
Anton;moore2009.pdf;cost-effectiveness of mri compared to mammography for breast cancer screening in a high risk population;Dhar, Asif  Meagher, Beth  Ryscavage, Andrew;
Anton;simms2016.pdf;cost-effectiveness of the next generation nonavalent human papillomavirus vaccine in the context of primary human papillomavirus screening in australia a comparative modelling analysis;Wang, Zixing, Wang, Yuyan, Huang, Yao, Xue, Fang, Han, Wei, Hu, Yaoda, Wang, Lei, Song, Wei, Jiang, Jingmei;
Anton;zhang2016.pdf;estimating long-term clinical effectiveness and cost-effectiveness of hpv 1618 vaccine in china;Wolf, Andrew M. D.  Fontham, Elizabeth T. H.  Church, Timothy R.  Flowers, Christopher R.  Guerra, Carmen E.  LaMonte, Samuel J.  Etzioni, Ruth  McKenna, Matthew T.  Oeffinger, Kevin C.  Shih, Ya-Chen Tina  Walter, Louise C.  Andrews, Kimberly S.  Brawley, Otis W.  Brooks, Durado  Fedewa, Stacey A.  Manassaram-Baptiste, Deana  Siegel, Rebecca L.  Wender, Richard C.  Smith, Robert A.;
Anton;kim2008.pdf;Exploring the cost-effectiveness of HPV vaccination in Vietnam: Insights for evidence-based cervical cancer prevention policy;Trentham-Dietz, Amy  Ergun, Mehmet Ali  Alagoz, Oguzhan  Stout, Natasha K.  Gangnon, Ronald E.  Hampton, John M.  Dittus, Kim  James, Ted A.  Vacek, Pamela M.  Herschorn, Sally D.  Burnside, Elizabeth S.  Tosteson, Anna N. A.  Weaver, Donald L.  Sprague, Brian L.;
Anton;shi2011.pdf;exploring the uncertainties of early detection results model-based interpretation of mayo lung project;de Carvalho, Tiago M., Heijnsdijk, Eveline A. M., de Koning, Harry J.;
Anton;gomez2014.pdf;health economic analysis of human papillomavirus vaccines in women of chile perspective of the health care payer using a markov model;van den Broek, Jeroen J., van Ravesteyn, Nicolien T., Mandelblatt, Jeanne S., Huang, Hui, Ergun, Mehmet Ali, Burnside, Elizabeth S., Xu, Cong, Li, Yisheng, Alagoz, Oguzhan, Lee, Sandra J., Stout, Natasha K., Song, Juhee, Trentham-Dietz, Amy, Plevritis, Sylvia K., Moss, Sue M., de Koning, Harry J.;
Anton;schlecht2003.pdf;modeling the time dependence of the association between human papillomavirus infection and cervical cancer precursor lesions;Arrospide, Arantzazu, Idigoras, Isabel, Mar, Javier, de Koning, Harry, van der Meulen, Miriam, Soto-Gordoa, Myriam, Miguel Martinez-Llorente, Jose, Portillo, Isabel, Arana-Arri, Eunate, Ibarrondo, Oliver, Lansdorp-Vogelaar, Iris;
Anton;roth2015.pdf;projected clinical resource use and fiscal impacts of implementing low-dose computed tomography lung cancer screening in medicare;Melnitchouk, Nelya, Soeteman, Djora I., Davids, Jennifer S., Fields, Adam, Cohen, Joshua, Noubary, Farzad, Lukashenko, Andrey, Kolesnik, Olena O., Freund, Karen M.;
Anton;hestbech2015.pdf;the impact of hpv vaccination on future cervical screening a simulation study of two birth cohorts in denmark;Sun, Li, Legood, Rosa, Sadique, Zia, dos-Santos-Silva, Isabel, Yang, Li;
Anton;barnett2017.pdf;two-stage biomarker protocols for improving the precision of early detection of prostate cancer;Silva-Illanes N, Espinoza M.;
Anton;nevalainen2017.pdf;what explains the differences between centres in the european screening trial a simulation study;Wheeler, Stephanie B., Leeman, Jennifer, Lich, Kristen Hassmiller, Tangka, Florence K. L., Davis, Melinda M., Richardson, Lisa C.;
Anton;hassan2012.pdf;loss of efficacy and cost-effectiveness when screening colonoscopy is performed by nongastroenterologists;Research Support, Non-U.S. Gov't,Adult,Age Factors,Aged,Breast Neoplasms/economics*,Breast Neoplasms/ethnology,Breast Neoplasms/prevention & control*,Cost-Benefit Analysis,Early Detection of Cancer/economics*,Female,Hong Kong,Humans,Longitudinal Studies,Mammography/economics*,Markov Chains,Mass Screening/economics*,Mass Screening/methods,Middle Aged;
Anton;schillerfruehwirth2017.pdf;the long-term effectiveness and cost-effectiveness of organized versus opportunistic screening for breast cancer in austria;BMJ.  Aug .():-.;
Anton;akhavantabatabaei2016.pdf;a markov decision process model for cervical cancer screening policies in colombia;Eur J Public Health.  Apr.():-. doi: ./eurpub/ckp. Epub  Oct .;
Anton;wu2012.pdf;The Lead Time Distribution When Lifetime is Subject to Competing Risks in Cancer Screening;Gastrointest Endosc Clin N Am.  Jan.():-.;
Anton;nihms458845.pdf;how should individuals with a false-positive fecal occult blood test for colorectal cancer be managed a decision analysis;Kafadar, K  Prorok, C;
Anton;10.1093@epirev@mxr009.pdf;interpreting overdiagnosis estimates in population-based mammography screening;Szucs T.D., Largeron N., Dedes K.J., Rafia R., Benard S.;
Anton;10.1002@ijc.29136.pdf;Screening for prostate cancer in the US? Reduce the harms and keep the benefit;Chesson HW, Ekwueme DU, Saraiya M, Markowitz LE.;
Anton;10.1002@ijc.29976.pdf;estimating the individual benefit of immediate treatment or active surveillance for prostate cancer after screen-detection in older 65 men;Lee KJ, Inoue M, Otani T, Iwasaki M, Sasazuki S, Tsugane S. Japan Public Health Center-based Prospective Study.;
Anton;10.1038@bjc.2011.300.pdf;prediction of higher mortality reduction for the uk breast screening frequency trial a model-based approach on screening intervals;Ladabaum, Uri  Ferrandez, Angel  Lanas, Angel;
Anton;10.2307@40271855.pdf;quantifying the role of psa screening in the us prostate cancer mortality decline;Vijayaraghavan, Arthi  Efrusy, Molly B.  Mayrand, Marie-Helene  Santas, Christopher C.  Goggin, Patricia;
Anton;10.1007@s00038-011-0273-5.pdf;public health impact of human papillomavirus vaccination on prevention of cervical cancer in france;Groenewoud, J. H.  Otten, J. D. M.  Fracheboud, J.  Draisma, G.  van Ineveld, B. M.  Holland, R.  Verbeek, A. L. M.  de Koning, H. J.;
Anton;10.1080@21645515.2015.1054584.pdf;Projected impact of Cervarix vaccination on oncogenic human papillomavirus infection and cervical cancer in the United Kingdom;Pickhardt, Perry J.  Hassan, Cesare  Laghi, Andrea  Zullo, Angelo  Kim, David H.  Morini, Sergio;
Anton;10.1016@s0959-80490000330-0.pdf;Overview of important cervical cancer screening process values inEuropean Union (EU) countries, and tentative predictions of the corresponding effectiveness and cost-effectiveness;Vaccine.  Dec . Suppl :H-. doi: ./j.vaccine....;
Anton;goldie2003.pdf;a potential error in evaluating cancer screening a comparison of 2 approaches for modeling underlying disease progression;;
Anton;stollenwerk2012.pdf;accounting for increased non-target-disease-specific mortality in decision-analytic screening models for economic evaluation;;
Anton;borrs1998.pdf;anticipating the consequences for the primary therapy of breast cancer after introducing screening - a more global picture for health care policy making;;
Anton;ijpr-14-635.pdf;applying a simple model of cost-effectiveness study of hpv vaccine for iran;;
Anton;hsieh2013.pdf;bayesian spatial analysis for the evaluation of breast cancer detection methods;;
Anton;sprague2015.pdf;Benefits, Harms, and cost-effectiveness of Supplemental Ultrasonography Screening for Women With Dense Breasts;;
Anton;ladabaum2006.pdf;colorectal cancer screening - differential costs for younger versus older americans;;
Anton;cleemput2009.pdf;cost-effectiveness Evaluation of a Quadrivalent Human Papillomavirus Vaccine in Belgium;;
Anton;torvinen2010.pdf;cost-effectiveness of prophylactic hpv 1618 vaccination in finland results from a modelling exercise;;
Anton;brisson2009.pdf;economic evaluation of human papillomavirus vaccination in developed countries;;
Anton;vanni2010.pdf;economic evaluation of strategies for managing women with equivocal cytological results in brazil;;
Anton;vanni2012.pdf;economic modelling assessment of the hpv quadrivalent vaccine in brazil a dynamic individual-based approach;;
Anton;weedonfekjaer2008.pdf;estimating mean sojourn time and screening sensitivity using questionnaire data on time since previous screening;;
Anton;kim2012.pdf;estimation of sensitivity depending on sojourn time and time spent in preclinical state;;
Anton;westvik2018.pdf;evaluating different breast tumor progression models using screening data;;
Anton;draisma2006.pdf;gleason score age and screening modeling dedifferentiation in prostate cancer;;
Anton;ekwueme2014.pdf;Impact of the National Breast and Cervical Cancer Early Detection Program on Cervical Cancer Mortality Among Uninsured Low-Income Womenin the U.S., 1991?2007;;
Anton;price2016.pdf;Operations research models and methods in the screening, detection, and treatment of prostate cancer: A categorized, annotated review;;
Anton;yang2018.pdf;quality assurance target for community-based breast cancer screening in china a model simulation;;
Anton;korostil2014.pdf;The potential impact of HPV-16 reactivation on prevalence in older Australians;;
Anton;choi2010.pdf;transmission dynamic modelling of the impact of human papillomavirus vaccination in the united kingdom;;
Anton;rutter2016.pdf;validation of models used to inform colorectal cancer screening guidelines accuracy and implications;;
Anton;10.1097@00006250-200312000-00035.pdf;Association of funding and conclusions in randomized drug trials: A reflection of treatment effect or adverse events?;;
Deleted;leshno2003_article_cost-effectivenessofcolorectal.pdf;cost-effectiveness of colorectal cancer screening in the average risk population;Ramsey, SD, McIntosh, M, Etzioni, R, Urban, N;
Deleted;a_proposal_for_an_evidence-based_model_of_the_scre.pdf;a proposal for an evidence-based model of the screening for the colorectal carcinoma in an italian setting;Choi YH, Jit M, Gay N, Cox A, Garnett GP, Edmunds WJ.;
Deleted;effective_screening_programmes.pdf;Effective screening programmes for cervical cancer in low- and middle-income developing countries;;
Deleted;shti129-0078.pdf;multiple detection modalities and disease natural history of breast cancer;;
Deleted;cdc_57174_ds1.pdf;data-powered participatory decision making leveraging systems thinking and simulation to guide selection and implementation of evidence-based colorectal cancer screening interventions;Sharp, Linda, Tilson, Lesley, Whyte, Sophie, Ceilleachair, Alan O., Walsh, Cathal, Usher, Cara, Tappenden, Paul, Chilcott, James, Staines, Anthony, Barry, Michael, Comber, Harry;
Deleted;optimizing_canadian_breast_can.pdf;Optimizing Canadian Breast Cancer Screening Strategies: A Perspective for Action;Mandelblatt, Jeanne, van Ravesteyn, Nicolien, Schechter, Clyde, Chang, Yaojen, Huang, An-Tsun, Near, Aimee M., de Koning, Harry, Jemal, Ahmedin;
Deleted;roso-llorach_sort2014.pdf;Assessing the impact of early detection biases on breast cancer survival of Catalan women;Bergstrom R., Sparen P., Adami H.-O.;
Deleted;1-s2.0-s0016510701901014-main.pdf;cost-effectiveness of screening for colorectal cancer in the general population;Carney, Timothy Jay, Morgan, Geoffrey P., Jones, Josette, McDaniel, Anna M., Weaver, Michael, Weiner, Bryan, Haggstrom, David A.;
Deleted;garcia2014.pdf;cost of the cervical cancer screening program at the mexican social security institute;Beaber EF, Kim JJ, Schapira MM, Tosteson AN, Zauber AG, Geiger AM, Kamineni A, Weaver DL, Tiro JA. Population-based Research Optimizing Screening through Personalized Regimens Consortium.;
Deleted;12885_2017_article_3786.pdf;estimating the value of point-of-care hpv testing in three low- and middle-income countries a modeling study;Coldman, A. J., Phillips, N., Brisson, J., Flanagan, W., Wolfson, M., Nadeau, C., Fitzgerald, N., Miller, A. B.;
Deleted;chen_et_al-2000-biometrics.pdf;estimation of sojourn time in chronic disease screening without data on interval cases;Rutter, Carolyn M.  Knudsen, Amy B.  Marsh, Tracey L.  Doria-Rose, V. Paul  Johnson, Eric  Pabiniak, Chester  Kuntz, Karen M.  van Ballegooijen, Marjolein  Zauber, Ann G.  Lansdorp-Vogelaar, Iris;
Deleted;1-s2.0-s0959804901002040-main.pdf;canadas population health model pohem a tool for performing economic evaluations of cancer control interventions;Barnett, Christine L.  Tomlins, Scott A.  Underwood, Daniel J.  Wei, John T.  Morgan, Todd M.  Montie, James E.  Denton, Brian T.;
Deleted;rossum_et_al-2011-international_journal_of_cancer.pdf;colorectal cancer screening comparing no screening immunochemical and guaiac fecal occult blood tests a cost-effectiveness analysis;Campbell, Leslie Anne, Blake, John T., Kephart, George, Grunfeld, Eva, MacIntosh, Donald;
Deleted;hta-06-05.pdf;Decision-analytic modeling to evaluate the long-term effectiveness and cost-effectiveness of HPV-DNA testing in primary cervical cancer screening in Germany;Taghipour S, Caudrelier LN, Miller AB, Harvey B.;
Deleted;wjg-11-1587.pdf;Feasible economic strategies to improve screening compliance for colorectal cancer in Korea;Nevalainen, Jaakko  Stenman, Ulf-Hakan  Tammela, Teuvo L.  Roobol, Monique  Carlssone, Sigrid  Talalag, Kirsi  Schroder, Fritz H.  Auvinen, Anssi;
Deleted;shti107-0104.pdf;cost-effectiveness analysis of colorectal cancer screening  strategies in Singapore: A dynamic decision analytic approach;Duffy SW, Raji OY, Agbaje OF, Allgood PC, Cassidy A, Field JK.;
Deleted;blt.18.207944.pdf;cost-effectiveness of risk-based breast cancer screening programme china;Ramos M, Ferrer S, Villaescusa JI, Verd? G, Salas MD, Cuevas MD.;
Deleted;11808-20809-2-pb.pdf;parametric and nonparametric two-sample tests for feature screening in class comparison a simulation study;Belkar R, Fiebig DG, Haas M, Viney R.;
Deleted;apjcp_volume 16_issue 6_pages 2317-2322.pdf;cost-effectiveness analysis of cervical cancer screening strategies based on the papanicolaou smear test in korea;Baker RD.;
Deleted;apjcp_volume 15_issue 15_pages 6177-6180.pdf;hpv vaccination for cervical cancer prevention is not cost-effective in japan;Lynge E, Clausen LB, Guignard R, Poll P.;
Deleted;ajph.2018.304659.pdf;lung cancer screening a cost-effective public health imperative;Colonoscopy/economics,Colorectal Neoplasms/mortality,Colorectal Neoplasms/prevention & control*,Cost-Benefit Analysis,Female,Humans,Male,Markov Chains,Mass Screening/economics*,Middle Aged,Occult Blood,Sigmoidoscopy/economics,Survival Analysis;
Deleted;10.1158@1055-9965.epi-10-0944.pdf;race-specific impact of natural history mammography screening and adjuvant treatment on breast cancer mortality rates in the united states;;
Deleted;apjcp_volume 13_issue 5_pages 1761-1766.pdf;repeat colonoscopy every 10 years or single colonoscopy for colorectal neoplasm screening in average-risk chinese a cost-effectiveness analysis;;
Deleted;jama_kim_2018_us_170016.pdf;screening for cervical cancer in primary care a decision analysis for the us preventive services task force;;
Deleted;aime201710170-m162891.pdf;screening for colorectal cancer with fecal immunochemical testing with and without postpolypectomy surveillance colonoscopy a cost-effectiveness analysis;;
Deleted;rosenquist_et_al-1998-cancer.pdf;Screening Mammography Beginning at Age 40 Years A Reappraisal of cost-effectiveness;;
Deleted;1-s2.0-s0022534701679321-main.pdf;SERIAL PROSTATE SPECIFIC ANTIGEN SCREENING FOR PROSTATECANCER: A COMPUTER MODEL EVALUATES COMPETING STRATEGIES;;
Deleted;ajmc_03_2016_wright (final).pdf;the budget impact of cervical cancer screening using hpv primary screening;;
Deleted;apjcp_volume 9_issue 3_pages 459-466.pdf;The cost-effectiveness of a Quadrivalent Human Papillomavirus Vaccine in Taiwan;;
Deleted;rossum_et_al-2011-international_journal_of_cancer.pdf;the cost-effectiveness of screening for colorectal cancer;;
Deleted;12913_2016_article_1662.pdf;the economic evaluation of human papillomavirus vaccination strategies against cervical cancer in women in lao pdr a mathematical modelling approach;;
Deleted;malik2013.pdf;the impact of an imperfect vaccine and pap cytology screening on the transmission of human papillomavirus and occurrence of associated cervical dysplasia and cancer;;
Deleted;1-s2.0-s0749379714006680-main.pdf;transition from film to digital mammography impact for breast cancer screening through the national breast and cervical cancer early detection program;;
Deleted;baker1998_article_useofamathematicalmodeltoevalu.pdf;use of a mathematical model to evaluate breast cancer screening policy;;
Deleted;12199_2008_article_53111.pdf;cost-effectiveness Analysis of Prostate Cancer Screening;;
Deleted;goffinetaljamaonc2015.pdf;cost-effectiveness of Lung Cancer Screening in Canada;;
Deleted;1-s2.0-s0090825810005251-main.pdf;cost-effectiveness of using human papillomavirus 16/18 genotype triage in cervical cancer screening;;
Deleted;bookshelf_nbk34013.pdf;Evaluating Test Strategies for Colorectal Cancer Screening? Age to Begin, Age to Stop, and Timing of Screening Intervals: A Decision Analysis of Colorectal Cancer Screening for the U.S. Preventive Services Task Force from the Cancer Intervention and Surveillance Modeling Network (CISNET);;
Deleted;vogelaar_et_al-2006-cancer.pdf;How Much Can Current Interventions Reduce Colorectal Cancer Mortality in the U.S.?;;
FromReview;flehinger1987.pdf;The Natural History of Lung Cancer in a Periodically Screened Population;BMC Health Serv Res.  Dec .:. doi: ./---.;
FromReview;glick1998.pdf;cost-effectiveness of Double-Contrast Barium Enema in Screening for Colorectal Cancer;Loeve, F, Brown, ML, Boer, R, van Ballegooijen, M, van Oortmarssen, GJ, Habbema, JDF;
FromReview;khandker2000.pdf;A DECISION MODEL AND cost-effectiveness ANALYSIS OF COLORECTAL CANCER SCREENING AND SURVEILLANCE GUIDELINES FOR AVERAGE-RISK ADULTS;Armaroli P, Gallo F, Bellomi A, Ciatto S, Consonni D, Davi D, Giorgi-Rossi P, Iossa A, Mancini E, Naldoni C, Polla E, Ronco G, Serafini M, Vergini V, Zanier L, Zappa M, Segnan N.;
FromReview;ross2000.pdf;Comparative efficiency of prostate-specific antigen screening strategies for prostate cancer detection.;Mandelblatt JS, Cronin KA, Bailey S, Berry DA, de Koning HJ, Draisma G, Huang H, Lee SJ, Munsell M, Plevritis SK, Ravdin P, Schechter CB, Sigal B, Stoto MA, Stout NK, van Ravesteyn NT, Venier J, Zelen M, Feuer EJ. Breast Cancer Working Group of the Cancer Intervention and Surveillance Modeling Network.;
FromReview;ness2000.pdf;Cost-Utility of One-Time Colonoscopic Screening for Colorectal Cancer at Various Ages;;
FromReview;lee2003.pdf;Modelling the early detection of breast cancer;Chen TH, Kuo HS, Yen MF, Lai MS, Tabar L, Duffy SW.;
FromReview;wisnivesky2003.pdf;The cost-effectiveness of Low-Dose CT Screening for Lung Cancer*Preliminary Results of Baseline Screening;Wang PE, Wang TT, Chiu YH, Yen AM, Chen TH.;
FromReview;rijnsburger2004.pdf;MAMMOGRAPHY BENEFIT IN THE CANADIAN NATIONAL BREASTSCREENING STUDY-2: A MODEL EVALUATION;Chang, Chi-Ming, Lin, Wen-Chou, Kuo, Hsu-Sung, Yen, Ming-Fang, Chen, Tony Hsiu-Hsi;
FromReview;shen2005.pdf;A Model-Based Comparison of Breast Cancer Screening Strategies: Mammograms and Clinical Breast Examinations;Duffy SW, Sasieni P, Olsen AH, Cafferty FH.;
FromReview;nejmoa2006.pdf;Colonoscopy in Colorectal-Cancer Screening for Detection of Advanced Neoplasia;Research Support, Non-U.S. Gov't,Aged,Breast Neoplasms/diagnosis*,Cohort Studies,Early Detection of Cancer/methods,Early Detection of Cancer/statistics & numerical data,False Positive Reactions*,Female,Humans,Mammography/psychology,Mammography/statistics & numerical data*,Mass Screening/methods*,Middle Aged,Proportional Hazards Models,Risk Factors;
FromReview;berry2006.pdf;Modeling the Impact of Treatment and Screening on U.S. Breast Cancer Mortality: A Bayesian Approach;Breast Cancer Res Treat.  Jul.():-. doi: ./s---x. Epub  Jan .;
FromReview;Karnon2006.pdf;A review and critique of modelling in prioritising and designing screening programmes;;
FromReview;tappenden2007.pdf;option appraisal of population-based colorectal cancer screening programmes in england;;
FromReview;Gamboa2008.pdf;cost-effectiveness of conventional cytology and hpv dna testing for cervical cancer screening in colombia;Lai MS, Yen MF, Kuo HS, Koong SL, Chen TH, Duffy SW.;
FromReview;chien2008.pdf;mean sojourn time and effectiveness of mortality reduction for lung cancer screening with computed tomography;Chien, Chun-Ru  Lai, Mei-Shu  Chen, Tony Hsiu-Hsi;
FromReview;chien2008.pdf;estimation of mean sojourn time for lung cancer by chest x-ray screening with a bayesian approach;Yen MS, You SL, Ferko N, Debicki D, Chen YC, Chou CY.;
FromReview;rodrguezmoranta2008.pdf;Endoscopic requirements of colorectal cancer screening programs in average-risk population. Estimation according to a Markov model;Bending M.W., Trueman P., Lowson K.V., Pilgrim H., Tappenden P., Chilcott J., Tappenden J.;
FromReview;chuck2010.pdf;cost-effectiveness of 21 Alternative Cervical Cancer Screening Strategies;J Med Screen. . Suppl :S-.;
FromReview;hassan2010.pdf;A Resect and Discard Strategy Would Improve cost-effectiveness ofColorectal Cancer Screening;Philips, Z, Whynes, DK;
FromReview;lansdorpvogelaar2010.pdf;Stool DNA Testing to Screen for Colorectal Cancer in the Medicare Population;Kim JJ, Kobus KE, Diaz M, O'Shea M, Van Minh H, Goldie SJ.;
FromReview;heitman2010.pdf;Colorectal Cancer Screening for Average-Risk North Americans: An Economic Evaluation;;
FromReview;kuntz2011.pdf;A Systematic Comparison of Microsimulation Models of Colorectal Cancer: The Role of Assumptions about Adenoma Progression;Brisson M, Van de Velde N, Boily MC.;
FromReview;balasubramanian2010.pdf;Accuracy and cost-effectiveness of Cervical Cancer Screening by High-Risk Human Papillomavirus DNA Testing of Self-Collected Vaginal Samples;Praditsitthikorn N, Teerawattananon Y, Tantivess S, Limwattananon S, Riewpaiboon A, Chichareon S, Ieumwananonthachai N, Tangcharoensathien V.;
FromReview;myles2003.pdf;Bayesian evaluation of breast cancer screening using data from two studies;Vanni T, Legood R, Franco EL, Villa LL, Luz PM, Schwartsmann G.;
FromReview;kim2004.pdf;cost-effectiveness of organized versus opportunistic cervical cytology screening in hong kong;Hoerger TJ, Ekwueme DU, Miller JW, Uzunangelov V, Hall IJ, Segel J, Royalty J, Gardner JG, Smith JL, Li C.;
FromReview;hassan2007.pdf;Colon cancer prevention in Italy: cost-effectiveness analysis with CT colonography and endoscopy;Vanni T, Luz PM, Foss A, Mesa-Frias M, Legood R.;
FromReview;nihms783893.pdf;modelling mammography screening for breast cancer in the canadian context modification and testing of a microsimulation model;Kim S., Wu D.;
FromReview;jeong2013.pdf;Review of economic evidence in the prevention and early detection of colorectal cancer;;
FromReview;vickers2013.pdf;comparative effectiveness of alternative prostate-specific antigen-based prostate cancer screening strategies model estimates of potential benefits and harms;Rue M, Vilaprinyo E, Lee S, Martinez-Alonso M, Carles MD, Marcos-Gragera R, Pla R, Espinas JA.;
FromReview;kearns2014.pdf;Guaiac faecal occult blood test performance at initial and repeat screens in the English Bowel Cancer Screening Programme;Kohli M, Ferko N, Martin A, Franco EL, Jenkins D, Gallivan S, Sherlaw-Johnson C, Drummond M.;
FromReview;beer2014.pdf;Does the HPV vaccination programme have implications for cervical screening programmes in the UK?;Weedon-Fekjaer H, Lindqvist BH, Vatten LJ, Aalen OO, Tretli S.;
FromReview;sroczynski2011.pdf;cost-effectiveness of primary hpv screening for cervical cancer in germany - a decision analysis;Gunsoy, N. B.  Garcia-Closas, M.  Moss, S. M.;
FromReview;munoz2014.pdf;Effects of Screening and Systemic Adjuvant Therapy on ER-Specific US Breast Cancer Mortality;Mvundura M, Tsu V.;
FromReview;nghiem2015.pdf;Economic evaluation of DNA ploidy analysis vs liquid-based cytology for cervical screening;Weedon-Fekjaer H, Tretli S, Aalen OO.;
FromReview;knudsen2010.pdf;cost-effectiveness of computed tomographic colonography screening for colorectal cancer in the medicare population;Hassan C., Rex D.K., Zullo A., Kaminski M.F.;
FromReview;underwood2012.pdf;simulation optimization of psa-threshold based prostate cancer screening policies;Arrospide A,,, Rue M,, van Ravesteyn NT, Comas M,, Larra??aga N,, Sarriugarte G, Mar J,,,.;
FromReview;lee2018.pdf;The Dana-Farber CISNET Model for BreastCancer Screening Strategies: An Update;Brenner, Hermann, Altenhofen, Lutz, Stock, Christian, Hoffmeister, Michael;
FromReview;okonkwo2008.pdf;breast cancer screening policies in developing countries a cost-effectiveness analysis for india;Arrospide A,,, Rue M,, van Ravesteyn NT, Comas M,, Soto-Gordoa M, Sarriugarte G, Mar J,,,.;
FromReview;creighton2010.pdf;Cervical cancer screening in Australia: modelled evaluation of the impact of changing the recommended interval from two to three years;Zhou, Jing, Zhao, Rongce, Wen, Feng, Zhang, Pengfei, Tang, Ruilei, Chen, Hongdou, Zhang, Jian, Li, Qiu;
FromReview;gyrdhansen1998.pdf;COLORECTAL CANCER SCREENING:EFFICIENCY AND EFFECTIVENESS;Liu YJ,, Zhang Q, Hu SY, Zhao FH.;
FromReview;cmaj_160_1_49.pdf;Current and projected annual direct costs of screening asymptomatic men for prostate cancer using prostate-specific antigen;Zhang Q, Liu YJ,, Hu SY, Zhao FH.;
FromReview;prevost1998.pdf;Estimating Sensitivity and Sojourn Time in Screening for Colorectal Cancer A Comparison of Statistical Approaches;Carlsson, Sigrid V.  de Carvalho, Tiago M.  Roobol, Monique J.  Hugosson, Jonas  Auvinen, Anssi  Kwiatkowski, Maciej  Villers, Arnauld  Zappa, Marco  Nelen, Vera  Paez, Alvaro  Eastham, James A.  Lilja, Hans  de Koning, Harry J.  Vickers, Andrew J.  Heijnsdijk, Eveline A. M.;
FromReview;pinsky2001.pdf;Estimation and Prediction for Cancer Screening Models Using Deconvolution and Smoothing;de Carvalho, Tiago M.  Heijnsdijk, Eveline A. M.  de Koning, Harry J.;
FromReview;stensson2013.pdf;Projected cost-effectiveness of repeat high-risk human papillomavirus testing using self-collected vaginal samples in the Swedish cervical cancer screening program;Tramontano AC, Sheehan DF, McMahon PM, Dowling EC, Holford TR, Ryczak K, Lesko SM, Levy DT, Kong CY.;
FromReview;dewilde2004.pdf;the cost-effectiveness of screening programs using single and multiple birth cohort simulations a comparison using a model of cervical cancer;Brenner, Hermann, Kretschmann, Jens, Stock, Christian, Hoffmeister, Michael;
FromReview;coup2009.pdf;How to screen for cervical cancer after HPV16/18 vaccination in The Netherlands;Campos NG, Tsu V, Jeronimo J, Mvundura M, Kim JJ.;
FromReview;zhang2011.pdf;Optimization of PSA Screening Policies: A Comparison of the Patient and Societal Perspectives;Sheehan DF, Criss SD, Gazelle GS,,, Pandharipande PV,, Kong CY,.;
FromReview;macafee2008.pdf;population screening for colorectal cancer the implications of an ageing population;Han, Summer S.  Erdogan, S. Ayca  Toumazis, Iakovos  Leung, Ann  Plevritis, Sylvia K.;
FromReview;lee1998.pdf;Scheduling Periodic Examinations for the Early Detection of Disease: Applications to Breast Cancer;Gray, Ewan  Donten, Anna  Karssemeijer, Nico  van Gils, Carla  Evans, D. Gareth  Astley, Sue  Payne, Katherine;
FromReview;gangnon2015.pdf;The Contribution of Mammography Screening to Breast Cancer Incidence Trends in the United States: An Updated Age-period-cohort Model;Idigoras, I., Arrospide, A., Portillo, I., Arana-Arri, E., Martinez-Indart, L., Mar, J., de Koning, H. J., Lastra, R., Soto-Gordoa, M., van der Meulen, M., Lansdorp-Vogelaar, I.;
FromReview;mandelblatt2016.pdf;Collaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening Strategies;Duarte, Elisa, de Sousa, Bruno, Cadarso-Suarez, Carmen, Kneib, Thomas, Rodrigues, Vitor;
FromReview;shen2005.pdf;a model-based comparison of breast cancer screening strategies mammograms and clinical breast examinations;Birnbaum, Jeanette K., Duggan, Catherine, Anderson, Benjamin O., Etzioni, Ruth;
FromReview;mandel1999.pdf;Colorectal Cancer Mortality: Effectiveness of Biennial Screening for Fecal Occult Blood;Rutter, Carolyn M., Kim, Jane J., Meester, Reinier G. S., Sprague, Brian L., Burger, Emily A., Zauber, Ann G., Ergun, Mehmet Ali, Campos, Nicole G., Doubeni, Chyke A., Trentham-Dietz, Amy, Sy, Stephen, Alagoz, Oguzhan, Stout, Natasha, Lansdorp-Vogelaar, Iris, Corley, Douglas A., Tosteson, Anna N. A.;
FromReview;pharoah2013.pdf;cost-effectiveness of the NHS breast screening programme: life table model;Munoz, Diego F.  Plevritis, Sylvia K.;
FromReview;zhang2012.pdf;Optimization of Prostate Biopsy Referral Decisions;Westvik, Asbjorn Schumacher  Weedon-Fekjaer, Harald  Maehlen, Jan  Liestol, Knut;
FromReview;mendes2015.pdf;Systematic review of model-based cervical screening evaluations;Lew, Jie-Bin, St John, D. James B., Macrae, Finlay A., Emery, Jon D., Ee, Hooi C., Jenkins, Mark A., He, Emily, Grogan, Paul, Caruana, Michael, Sarfati, Diana, Greuter, Marjolein J. E., Coupe, Veerle M. H., Canfell, Karen;
FromReview;10.1016@j.bpg.2010.07.001.pdf;Simulation of colorectal cancer screening: What we do and do not know and does it matter;Berkhof, J  de Bruijne, MC  Zielinski, GD  Bulkmans, NWJ  Rozendaal, L  Snijders, PJF  Verheijen, RHM  Meijer, CJLM;
FromReview;10.7326@m13-2263.pdf;Should Colorectal Cancer Screening Be Considered in Elderly Persons Without Previous Screening? A cost-effectiveness Analysis;;
FromReview;plevritis2001.pdf;A mathematical algorithm that computes breast cancer sizes and doubling times detected by screening.;;
FromReview;bailey2010.pdf;a simulation model investigating the impact of tumor volume doubling time and mammographic tumor detectability on screening outcomes in women aged 40-49 years;;
FromReview;sherlawjohnson2004.pdf;An evaluation of liquid-based cytology and human papillomavirus testing within the UK cervical cancer screening programme;;
FromReview;pence2012.pdf;Combination Aspirin and/or Calcium Chemoprevention with Colonoscopy in Colorectal Cancer Prevention: cost-effectiveness Analyses;;
FromReview;chen2007.pdf;cost-effectiveness analysis for determining optimal cut-off of immunochemical faecal occult blood test for population-based colorectal cancer screening (KCIS 16);;
FromReview;10.1016@j.ejca.2008.09.015.pdf;cost-effectiveness of opportunistic versus organised mammography screening in switzerland;;
FromReview;holmberg1998.pdf;Economic evaluation of screening for prostate cancer: a randomized population based programme during a 10-year period in Sweden;;
FromReview;etzioni2008.pdf;impact of psa screening on the incidence of advanced stage prostate cancer in the united states a surveillance modeling approach;;
Noneg;document(1).pdf;What is the most cost-effective screening regimen for colon cancer?;Vaccine.  Apr .():-. doi: ./j.vaccine.... Epub  Feb .;
Noneg;lgj007.pdf;the wisconsin breast cancer epidemiology simulation model;Boer R, de Koning H, van Oortmarssen G, Warmerdam P, van der Maas P.;
Noneg;1328.full.pdf;do men and women need to be screened differently with fecal immunochemical testing a cost-effectiveness analysis;Barratt A., Howard K., Irwig L., Salkeld G., Houssami N.;
Noneg;baker1998.pdf;evaluating the age to begin periodic breast cancer screening using data from a few regularly scheduled screenings;Canfell K.;
Noneg;loeve1999.pdf;the miscan-colon simulation model for the evaluation of colorectal cancer screening;Klemi PJ, Parvinen I, Pylkk?nen L, Kauhava L, Immonen-R?ih? P, R?s?nen O, Helenius H.;
Noneg;connor2000.pdf;investigation of design and bias issues in case-control studies of cancer screening using microsimulation;Marshall D, Simpson KN, Earle CC, Chu C.;
Noneg;philips2001.pdf;early withdrawal from cervical cancer screening the question of cost-effectiveness;Parmigiani, G, Skates, S, Zelen, M;
Noneg;loeve2001.pdf;impact of systematic false-negative test results on the performance of faecal occult blood screening;Etzioni, R  Penson, DF  Legler, JM  di Tommaso, D  Boer, R  Gann, PH  Feuer, EJ;
Noneg;wilson2001.pdf;model of estimated rates of colorectal cancer from polyp growth by year of surveillance;Sepp?nen J, Hein?vaara S, Hakulinen T.;
Noneg;johnston2001.pdf;modelling the future costs of breast screening;Tafazzoli, Ali, Roberts, Stephen, Klein, Robert, Ness, Reid, Dittus, Robert;
Noneg;marshall2001.pdf;Potential cost-effectiveness of one-time screening for lung cancer (LC) in a high risk cohort;Wever, Elisabeth M.  Draisma, Gerrit  Heijnsdijk, Eveline A. M.  Roobol, Monique J.  Boer, Rob  Otto, Suzie J.  de Koning, Harry J.;
Noneg;parmigiani2002.pdf;modeling and optimization in early detection programs with a single exam;Parkin, D. M., Tappenden, P., Olsen, A. H., Patnick, J., Sasieni, P.;
Noneg;klemi2003.pdf;significant improvement in breast cancer survival through population-based mammography screening;Ann Intern Med.  Nov .():-. doi: ./-----.;
Noneg;lejeune2004.pdf;cost-effective analysis of fecal occult blood screening for colorectal cancer;Montz FJ, Farber FL, Bristow RE, Cornelison T.;
Noneg;canfell2004.pdf;the predicted effect of changes in cervical screening practice in the uk results from a modelling study;Hunter DJ, Drake SM, Shortt SE, Dorland JL, Tran N.;
Noneg;hunter2004.pdf;simulation modeling of change to breast cancer detection age eligibility recommendations in ontario 2002-2021;Stout, NK  Rosenberg, MA  Trentham-Dietz, A  Smith, MA  Robinson, SM  Fryback, DG;
Noneg;manuel2004.pdf;cost-effectiveness analyses in gynecologic oncology methodological quality and trends;Etzioni, Ruth  Gulati, Roman  Falcon, Seth  Penson, David F.;
Noneg;stone2004.pdf;colorectal cancer screening in australia an economic evaluation of a potential biennial screening program using faecal occult blood tests;;
Noneg;berchi2004.pdf;cost-effectiveness analysis of two strategies for mass screening for colorectal cancer in france;Hassan C, Pickhardt PJ, Laghi A, Zullo A, Kim DH, Iafrate F, Di Giulio L, Morini S.;
Noneg;stone2005.pdf;prostate cancer the psa test and academic detailing in australian general practice an economic evaluation;Yen, MF  Tabar, L  Vitak, B  Smith, RA  Chen, HH  Duffy, SW;
Noneg;howard2005.pdf;High participation rates are not necessary for cost-effective colorectal cancer screening;Tappenden P, Chilcott J, Eggington S, Patnick J, Sakai H, Karnon J.;
Noneg;belkar2005.pdf;why worry about awareness in choice problems econometric analysis of screening for cervical cancer;Blanks RG.;
Noneg;lynge2006.pdf;What happens when organization of cervical cancer screening is delayed or stopped?;Dewilde S., Anderson R.;
Noneg;llewellyn2006.pdf;endoscopic colorectal cancer screening a cost-saving analysis;Demarteau N, Standaert B.;
Noneg;roberts2007.pdf;development of a simulation model of colorectal cancer;Wilson, LS, Lightwood, J;
Noneg;wong2007.pdf;cost-effectiveness of mammography screening for chinese women;Draisma, G  Boer, R  Otto, SJ  van der Cruijsen, IW  Damhuis, RAM  Schroder, FH  de Koning, HJ;
Noneg;chang2007.pdf;estimation and prediction system for multi-state disease process application to analysis of organized screening regime;McCann J, Treasure P, Duffy S.;
Noneg;koong2007.pdf;efficacy and cost-effectiveness of nationwide cervical cancer screening in taiwan;Nnoaham KE, Lines C.;
Noneg;anderson2008.pdf;the cost-effectiveness of cervical screening in australia what is the impact of screening at different intervals or over a different age range;Beemsterboer, PMM, Warmerdam, PG, Boer, R, Borras, JM, Moreno, V, Viladiu, P, De Koning, HJ;
Noneg;tsoi2008.pdf;cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in asia;Blanks RG, Moss SM, Denton K.;
Noneg;karnon2008.pdf;cost-utility analysis of screening high-risk groups for anal cancer;Chien, Chun-Ru  Chen, Tony Hsiu-Hsi;
Noneg;wu2009.pdf;a projection of benefits due to fecal occult blood test for colorectal cancer;;
Noneg;molins2009.pdf;effect of participation on the cumulative risk of false-positive recall in a breast cancer screening programme;Cancer Epidemiol Biomarkers Prev.  Jul.():-. doi: ./-.EPI--. Epub  Jun .;
Noneg;mandelblatt2009.pdf;effects of mammography screening under different screening schedules model estimates of potential benefits and harms;Schlecht N.F., Platt R.W., Negassa A., Duarte-Franco E., Rohan T.E., Ferenczy A., Villa L.L., Franco E.L.;
Noneg;kulasingam2009.pdf;Human papillomavirus testing with Pap triage for cervical cancer prevention in Canada: a cost-effectiveness analysis;Duffy, SW  Agbaje, O  Tabar, L  Vitak, B  Bjurstam, N  Bjorneld, L  Myles, JP  Warwick, J;
Noneg;rue2009.pdf;effectiveness of early detection on breast cancer mortality reduction in catalonia spain;Berry DA, Inoue L, Shen Y, Venier J, Cohen D, Bondy M, Theriault R, Munsell MF.;
Noneg;hassan2009.pdf;impact of whole-body ct screening on the cost-effectiveness of ct colonography;Olsen A.H., Agbaje O.F., Myles J.P., Lynge E., Duffy S.W.;
Noneg;weedonfekjaer2010.pdf;Estimating screening test sensitivity and tumour progression using tumour size and time since previous screening;Comment,Female,Humans,Models, Statistical,Population Surveillance*,United Kingdom/epidemiology,Uterine Cervical Neoplasms/diagnosis*,Uterine Cervical Neoplasms/epidemiology,Uterine Cervical Neoplasms/mortality;
Noneg;lee2010.pdf;cost-effectiveness of ct colonography for uk nhs colorectal cancer screening of asymptomatic adults aged 60-69 years;;
Noneg;agorastos2010.pdf;effect of type-specific human papillomavirus incidence on screening performance and cost;Feuer EJ, Mariotto A, Merrill R.;
Noneg;wu2010.pdf;estimation of natural history parameters of breast cancer based on non-randomized organized screening data subsidiary analysis of effects of inter-screening interval sensitivity and attendance rate on reduction of advanced cancer;Woo P.P.S., Thach T.Q., Choy S.T.B., McGhee S.M., Leung G.M.;
Noneg;chiu2010.pdf;analytical decision model for sample size and effectiveness projections for use in planning a population-based randomized controlled trial of colorectal cancer screening;Draisma, Gerrit  Postma, Renske  Schroder, Fritz H.  van der Kwast, Theo H.  de Koning, Harry J.;
Noneg;taylor2010.pdf;modelling the impact of changes in sensitivity on the outcomes of the uk breast screening programme;Rojnik K, Naversnik K, Mateovi??-Rojnik T, Primiczakelj M.;
Noneg;bending2010.pdf;estimating the direct costs of bowel cancer services provided by the national health service in england;Taylor P.;
Noneg;chauvin2011.pdf;incremental net benefit and acceptability of alternative health policies a case study of mass screening for colorectal cancer;Van Ballegooijen M., Van den Akker-van Marle E., Patnick J., Lynge E., Arbyn M., Anttila A., Ronco G., Dik J., Habbema F.;
Noneg;carles2011.pdf;cost-effectiveness of early detection of breast cancer in catalonia spain;Pickhardt P.J., Hassan C., Laghi A., Kim D.H., Zullo A., Iafrate F., Morini S.;
Noneg;russell2011.pdf;exploring the unknown and the unknowable with simulation models;Rogoza RM, Ferko N, Bentley J, Meijer CJ, Berkhof J, Wang KL, Downs L, Smith JS, Franco EL.;
Noneg;carter2003.pdf;A computer model for the study of breast cancer;Shi, Lu  Tian, Haijun  McCarthy, William J.  Berman, Barbara  Wu, Shinyi  Boer, Rob;
Noneg;lejeune2003.pdf;A simulation model for evaluating the medical and economic outcomes of screening strategies for colorectal cancer;Fisher R, Rooney PS.;
Noneg;vacek2011.pdf;breast cancer risk assessment in women aged 70 and older;Wever EM, Draisma G, Heijnsdijk EA, de Koning HJ.;
Noneg;michaelson1999.pdf;Breast cancer: computer simulation method for estimating optimal intervals for screening.;Wilschut, Janneke A., Steyerberg, Ewout W., van Leerdam, Monique E., Lansdorp-Vogelaar, Iris, Habbema, J. Dik F., van Ballegooijen, Marjolein;
Noneg;10.1177@0272989x11408915.pdf;clarifying differences in natural history between models of screening the case of colorectal cancer;Flores Y.N., Bishai D.M., Lorincz A., Shah K.V., Lazcano-Ponce E., Hernandez M., Granados-Garcia V., Perez R., Salmeron J.;
Noneg;lee2007.pdf;colorectal cancer screening using fecal occult blood test and subsequent risk of colorectal cancer a prospective cohort study in japan;Jit M, Demarteau N, Elbasha E, Ginsberg G, Kim J, Praditsitthikorn N, Sinanovic E, Hutubessy R.;
Noneg;gocgun2015.pdf;cost-effectiveness of breast cancer screening policies using simulation;de Gelder R, Heijnsdijk EA, van Ravesteyn NT, Fracheboud J, Draisma G, de Koning HJ.;
Noneg;lejeune2010.pdf;cost-effectiveness of screening for colorectal cancer in france using a guaiac test versus an immunochemical test;Lefevere E, Hens N, Theeten H, Van den Bosch K, Beutels P, De Smet F, Van Damme P.;
Noneg;armaroli2008.pdf;do women or50 years of age need as much screening as women 50 years after they have had negative screening results;Goldie S.J., Daniels N.;
Noneg;chen2010.pdf;estimating key parameters in periodic breast cancer screening-application to the canadian national breast screening study data;Uhry Z, H??delin G, Colonna M, Asselain B, Arveux P, Exbrayat C, Guldenfelds C, Soler-Michel P, Molini?? F, Tr??tarre B, Rogel A, Courtial I, Danzon A, Guizard AV, Ancelle-Park R, Eilstein D, Duffy S.;
Noneg;nnoaham2008.pdf;modelling future capacity needs and spending on colonoscopy in the english bowel cancer screening programme;van Ravesteyn, N. T.  Heijnsdijk, E. A. M.  Draisma, G.  de Koning, H. J.;
Noneg;uhry2011.pdf;modelling the effect of breast cancer screening on related mortality using french data;Canfell K, Shi JF, Lew JB, Walker R, Zhao FH, Simonella L, Chen JF, Legood R, Smith MA, Nickson C, Qiao YL.;
Noneg;woo2005.pdf;modelling the impact of population-based cytologic screening on cervical cancer incidence and mortality in hong kong an age-period-cohort approach;Bradley, Cathy J., Lansdorp-Vogelaar, Iris, Yabroff, Robin, Dahman, Bassam, Mariotto, Angela, Feuer, Eric J., Brown, Martin L.;
Noneg;whyte2012.pdf;reappraisal of the options for colorectal cancer screening in england;van Ravesteyn, Nicolien T.  Schechter, Clyde B.  Near, Aimee M.  Heijnsdijk, Eveline A. M.  Stoto, Michael A.  Draisma, Gerrit  de Koning, Harry J.  Mandelblatt, Jeanne S.;
Noneg;knudsen2012.pdf;rescreening of persons with a negative colonoscopy result results from a microsimulation model;Eaker S., Adami H.-O., Sparen P.;
Noneg;morrell2012.pdf;risk of cervical cancer associated with extending the interval between cervical-cancer screenings;Bouee, S., Fagnani, F., Alfonsi, A., Florentin, V;
Noneg;mandelblatt2002.pdf;Benefits and costs of using HPV testing to screen for cervical cancer.;Vanagas G, Padaiga Z.;
Noneg;arveux2003.pdf;building a model to determine the cost-effectiveness of breast cancer screening in france;Haug U, Knudsen AB, Kuntz KM.;
Noneg;joseph2016.pdf;colorectal cancer screening estimated future colonoscopy need and current volume and capacity;Crowcroft N.S., Hamid J.S., Deeks S.L., Frank J.;
Noneg;pil2016.pdf;cost-effectiveness and budget impact analysis of a population-based screening program for colorectal cancer;Chauvin P, Josselin JM, Heresbach D.;
Noneg;berkhof2013.pdf;cost-effectiveness of cervical cancer prevention in central and eastern europe and central asia;Yamamoto N, Mori R, Jacklin P, Osuga Y, Kawana K, Shibuya K, Taketani Y.;
Noneg;nihms307273.pdf;costs and cost-effectiveness of full implementation of a biennial faecal occult blood test screening program for bowel cancer in australia;Hassan, Cesare  Rex, Douglas K.  Zullo, Angelo  Cooper, Gregory S.;
Noneg;sheehan2017.pdf;evaluating lung cancer screening in china implications for eligibility criteria design from a microsimulation modeling approach;Gunsoy, Necdet B.  Garcia-Closas, Montserrat  Moss, Sue M.;
Noneg;sharma2008.pdf;fecal occult blood testing best option for colorectal cancer screening in asia;Barisic, Andriana  Taghipour, Sharareh  Banjevic, Dragan  Miller, Anthony B.  Montgomery, Neil  Jardine, Andrew  Harvey, Bart J.;
Noneg;krahn2013.pdf;health care costs for state transition models in prostate cancer;Cancer.  Sep .():-. doi: ./cncr.. Epub  Feb .;
Noneg;blanks2006.pdf;improving the nhs cervical screening laboratory performance indicators by making allowance for population age risk and screening interval;Cancer Epidemiol Biomarkers Prev.  May.():-. doi: ./-.EPI--. Epub  Feb .;
Noneg;etzioni2004.pdf;modelling the effect of screening for cervical cancer on the population;de Kok IM, van Rosmalen J, Dillner J, Arbyn M, Sasieni P, Iftner T, van Ballegooijen M.;
Noneg;castanon2018.pdf;prediction of cervical cancer incidence in england uk up to 2040 under four scenarios a modelling study;El Hasnaoui A, Demarteau N, Granados D, Standaert B, Detournay B.;
Noneg;melnikow2013.pdf;program-specific cost-effectiveness analysis breast cancer screening policies for a safety-net program;Lang HC, Chang K, Ying YH.;
Noneg;bouee2009.pdf;relative impact of screening and therapeutic progress on the reduction of breast cancer specific mortality in france a simulation model over the period 1994-2005;Whyte S, Chilcott J, Halloran S.;
Noneg;beemsterboer1998.pdf;screening for breast cancer in catalonia - which policy is to be preferred;Wang, Zhen-Hua, Gao, Qin-Yan, Fang, Jing-Yuan;
Noneg;siddiqui2011.pdf;the role of physician reminders in faecal occult blood testing for colorectal cancer screening;Underwood, Daniel J.  Zhang, Jingyu  Denton, Brian T.  Shah, Nilay D.  Inman, Brant A.;
Noneg;ma2013.pdf;annual number of lung cancer deaths potentially avertable by screening in the united states;PLoS One.  Mar .():e. doi: ./journal.pone.. eCollection .;
Noneg;arrospide2013.pdf;An assessment of existing models for individualized breast cancer risk estimation in a screening program in Spain;News,Aged,Asia, Southeastern/epidemiology,Colonoscopy/economics,Colorectal Neoplasms/diagnosis*,Colorectal Neoplasms/economics,Colorectal Neoplasms/epidemiology,Colorectal Neoplasms/prevention & control*,Cost-Benefit Analysis,Far East/epidemiology,Humans,Incidence,Markov Chains,Mass Screening/economics*,Mass Screening/methods*,Middle Aged,Occult Blood*,Patient Compliance,Practice Guidelines as Topic,Sigmoidoscopy/economics;
Noneg;park2013.pdf;korean risk assessment model for breast cancer risk prediction;Kulasingam SL, Myers ER.;
Noneg;hosking2013.pdf;investigating interventions for increasing colorectal cancer screening insights from a simulation model;Macafee, D. A. L.  Waller, M.  Whynes, D. K.  Moss, S.  Scholefield, J. H.;
Noneg;sharp2013.pdf;Using resource modelling to inform decision making and service planning: the case of colorectal cancer screening in Ireland;Anderson R, Haas M, Shanahan M.;
Noneg;timmers2013.pdf;breast cancer risk prediction model a nomogram based on common mammographic screening findings;Sasieni P., Castanon A., Parkin D.M.;
Noneg;arrospide2018.pdf;cost-effectiveness and budget impact analyses of a colorectal cancer screening programme in a high adenoma prevalence scenario using miscan-colon microsimulation model;Westra TA, Stirbu-Wagner I, Dorsman S, Tutuhatunewa ED, de Vrij EL, Nijman HW, Daemen T, Wilschut JC, Postma MJ.;
Noneg;mcmahon2011.pdf;cost-effectiveness of computed tomography screening for lung cancer in the united states;Hosking, Michael, Roberts, Stephen, Uzsoy, Reha, Joseph, Talisa M.;
Noneg;ouakrim2014.pdf;cost-effectiveness of family history-based colorectal cancer screening in Australia;Park B., Ma S.H., Shin A., Chang M.-C., Choi J.-Y., Kim S., Han W., Noh D.-Y., Ahn S.-H., Kang D., Yoo K.-Y., Park S.K.;
Noneg;376.pdf;cost-effectiveness of shortening screening interval or extending age range of nhs breast screening programme computer simulation study;Etzioni, Ruth  Gulati, Roman  Cooperberg, Matt R.  Penson, David M.  Weiss, Noel S.  Thompson, Ian M.;
Noneg;blanks2004.pdf;monitoring and evaluating the performance of the uk nhs cervical screening programme monitoring performance by using cytology outcomes adjusted for population characteristics;Melnikow J, Tancredi DJ, Yang Z, Ritley D, Jiang Y, Slee C, Popova S, Rylett P, Knutson K, Smalley S.;
Noneg;coldman2017.pdf;projected effect of fecal immunochemical test threshold for colorectal cancer screening on outcomes and costs for canada using the oncosim microsimulation model;Jansen RJ, Alexander BH, Anderson KE, Church TR.;
Noneg;dreyfuss2009.pdf;Simulation Model Predicts Cost Savings from Colorectal Cancer Screening;Etzioni, Ruth  Gulati, Roman;
Noneg;lgj010.pdf;the university of rochester model of breast cancer detection and survival;Goldwasser, Deborah L.  Kimmel, Marek;
Noneg;ramos2005.pdf;Use of risk projection models to estimate mortality and incidence from radiation-induced breast cancer in screening programs;Field JK, Chen Y, Marcus MW, Mcronald FE, Raji OY, Duffy SW.;
Noneg;campos2016.pdf;To Expand Coverage, or Increase Frequency: Quantifying the Tradeoffs between Equity and Efficiency Facing Cervical Cancer Screening Programs in Low-Resource Settings;Uuskula A., Muursepp A., Kawai K., Raag M., Jurisson M., Pillsbury M.;
Noneg;omahony2014.pdf;the influence of disease risk on the optimal time interval between screens for the early detection of cancer a mathematical approach;Myers ER, McCrory DC, Subramanian S, McCall N, Nanda K, Datta S, Matchar DB.;
Noneg;mvundura2014.pdf;estimating the costs of cervical cancer screening in high-burden sub-saharan african countries;Johnston K.;
Noneg;ahern2014.pdf;cost-effectiveness of alternative strategies for integrating mri into breast cancer screening for women at high risk;Berhane, K, Weissfeld, LA;
Noneg;heijnsdijk2014.pdf;re cost-effectiveness of prostate cancer screening a simulation study based on erspc data;Etzioni, Ruth  Tsodikov, Alex  Mariotto, Angela  Szabo, Aniko  Falcon, Seth  Wegelin, Jake  ditommaso, Dante  Karnofski, Kent  Gulati, Roman  Penson, David F.  Feuer, Eric;
Noneg;carney2014.pdf;using computational modeling to assess the impact of clinical decision support on cancer screening improvement strategies within the community health centers;Dasbach EJ, Insinga RP, Yang YC, Pwu RF, Lac C, Elbasha EH.;
Noneg;zai2014.pdf;applying operations research to optimize a novel population management system for cancer screening;Mennini FS, Giorgi Rossi P, Palazzo F, Largeron N.;
Noneg;armero2008.pdf;bayesian assessment of times to diagnosis in breast cancer screening;Krahn M.D., Bremner K.E., Zagorski B., Alibhai S.M.H., Chen W., Tomlinson G., Mitsakakis N., Naglie G.;
Noneg;hsu2017.pdf;bayesian negative-binomial-family-based multistate markov model for the evaluation of periodic population-based cancer screening considering incomplete information and measurement errors;Gomez JA, Lepetic A, Demarteau N.;
Noneg;prakash2017.pdf;cmost an open-source framework for the microsimulation of colorectal cancer screening strategies;Isshiki T.;
Noneg;cromwell2016.pdf;cost-effectiveness analysis of anal cancer screening in women with cervical neoplasia in british columbia canada;Blanch J, Sala M, Ib???ez J, Domingo L, Fernandez B, Otegi A, Barata T, Zubizarreta R, Ferrer J, Castells X, Ru?? M, Salas D. INCA Study Group.;
Noneg;hkm1006sp3p38.pdf;cost-effectiveness analysis of mammography screening in Hong Kong Chinese using state-transition Markov modelling;Ekwueme DU, Uzunangelov VJ, Hoerger TJ, Miller JW, Saraiya M, Benard VB, Hall IJ, Royalty J, Li C, Myers ER.;
Noneg;lucidarme2012.pdf;cost-effectiveness modeling of colorectal cancer computed tomography colonography vs colonoscopy or fecal occult blood tests;Gulati, Roman  Inoue, Lurdes Y. T.  Gore, John L.  Katcher, Jeffrey  Etzioni, Ruth;
Noneg;sankatsing2015.pdf;cost-effectiveness of digital mammography screening before the age of 50 in the netherlands;Pataky, Reka  Gulati, Roman  Etzioni, Ruth  Black, Peter  Chi, Kim N.  Coldman, Andrew J.  Pickles, Tom  Tyldesley, Scott  Peacock, Stuart;
Noneg;older.pdf;the value of colonoscopic colorectal cancer screening of adults aged 50 to 64 years;Yeh, Hung-Wen  Gajewski, Byron J.  Perdue, David G.  Cully, Angel  Cully, Lance  Greiner, K. Allen  Choi, Won S.  Daley, Christine Makosy;
Noneg;jgi_05076.pdf;toward optimal screening strategies for older women costs benefits and harms of breast cancer screening by age biology and health status;Kivuti-Bitok, Lucy W., McDonnell, Geoff, Abdul, Roudsari, Pokhariyal, Ganesh P.;
Noneg;taghipour2016.pdf;using simulation to model and validate invasive breast cancer progression in women in the study and control groups of the canadian national breast screening studies i and ii;Lejeune C, Le Gleut K, Cottet V, Galimard C, Durand G, Dancourt V, Faivre J.;
Noneg;goede2015.pdf;the impact of stratifying by family history in colorectal cancer screening programs;Rosenquist, CJ  Lindfors, KK;
Noneg;coldman2015.pdf;using the cancer risk management model to evaluate colorectal cancer screening options for canada;CMAJ.  Sep .():-. doi: ./cmaj.. Epub  Jul .;
Noneg;arrospide2015.pdf;evaluation of health benefits and harms of the breast cancer screening programme in the basque country using discrete event simulation;Uhry, Z.  Hedelin, G.  Colonna, M.  Asselain, B.  Arveux, P.  Rogel, A.  Exbrayat, C.  Guldenfels, C.  Courtial, I.  Soler-Michel, P.  Molinie, F.  Eilstein, D.  Duffy, S. W.;
Noneg;provenzale2002.pdf;cost-effectiveness of screening the average-risk population for colorectal cancer;Geurts, S. M. E.  Massat, N. J.  Duffy, S. W.;
Noneg;hassan2015.pdf;efficacy and cost-effectiveness of screening colonoscopy according to the adenoma detection rate;Yaffe, Martin J.  Mittmann, Nicole  Lee, Pablo  Tosteson, Anna N. A.  Trentham-Dietz, Amy  Alagoz, Oguzhan  Stout, Natasha K.;
Noneg;lew2012.pdf;Expenditure and resource utilisation for cervical screening in Australia;van der Steen, Alex  Knudsen, Amy B.  van Hees, Frank  Walter, Gailya P.  Berger, Franklin G.  Daguise, Virginie G.  Kuntz, Karen M.  Zauber, Ann G.  van Ballegooijen, Marjolein  Lansdorp-Vogelaar, Iris;
Noneg;duarte2017.pdf;Exploring risk factors in breast cancer screening program data using structured geoadditive models with high order interaction;Jpn J Clin Oncol.  Feb.():-. doi: ./jjco/hyv. Epub  Dec .;
Noneg;wilschut2011.pdf;how much colonoscopy screening should be recommended to individuals with various degrees of family history of colorectal cancer;Naversnik K.;
Noneg;blanch2014.pdf;impact of risk factors on different interval cancer subtypes in a population-based breast cancer screening programme;Seigneurin A., Labarere J., Duffy S.W., Colonna M.;
Noneg;rafia2015.pdf;Modeling the cost-effectiveness of Alternative Upper Age Limits for Breast Cancer Screening in England and Wales;Zelle SG, Baltussen R, Otten JD, Heijnsdijk EA, van Schoor G, Broeders MJ.;
Noneg;sutradhar2016.pdf;multistate transitional models for measuring adherence to breast cancer screening a population-based longitudinal cohort study with over two million women;Roth, Joshua A.  Sullivan, Sean D.  Goulart, Bernardo H. L.  Ravelo, Arliene  Sanderson, Joanna C.  Ramsey, Scott D.;
Noneg;wong2012.pdf;optimizing resource allocation for breast cancer prevention and care among hong kong chinese women;Birnbaum, Jeanette K.  Feng, Ziding  Gulati, Roman  Fan, Jing  Lotan, Yair  Wei, John T.  Etzioni, Ruth;
Noneg;parkin2008.pdf;predicting the impact of the screening programme for colorectal cancer in the uk;Meester, Reinier G. S.  Doubeni, Chyke A.  Zauber, Ann G.  Goede, S. Luuk  Levin, Theodore R.  Corley, Douglas A.  Jemal, Ahmedin  Lansdorp-Vogelaar, Iris;
Noneg;eaker2001.pdf;reasons women do not attend screening for cervical cancer a population-based study in sweden;Noordzij, M. Arjen, Blanker, Marco H.;
Noneg;lejeune2014.pdf;the cost-effectiveness of immunochemical tests for colorectal cancer screening;Ruile, Georg  Djanatliev, Anatoli  Kriza, Christine  Meier, Florian  Leb, Ines  Kalender, Willi A.  Kolominsky-Rabas, Peter L.;
Noneg;ventura2014.pdf;the impact of immunochemical faecal occult blood testing on colorectal cancer incidence;de Carvalho, Tiago M.  Heijnsdijk, Eveline A. M.  de Koning, Harry J.;
Noneg;10.7326@0003-4819-156-9-201205010-00002.pdf;tipping the balance of benefits and harms to favor screening mammography starting at age 40 years a comparative modeling study of risk;Lansdorp-Vogelaar, Iris  Goede, S. Lucas  Ma, Jiemin  Wu Xiau-Cheng  Pawlish, Karen  van Ballegooijen, Marjolein  Jemal, Ahmedin;
Noneg;sawaya2003.pdf;Risk of Cervical Cancer Associated with Extending the Interval between Cervical-Cancer Screenings;de Gelder R, Heijnsdijk EA, Fracheboud J, Draisma G, de Koning HJ.;
Noneg;tramontano2016.pdf;evaluating the impacts of screening and smoking cessation programmes on lung cancer in a high-burden region of the usa a simulation modelling study;Cytopathology.  Feb.():-.;
Noneg;sharma2016.pdf;cost-effectiveness of increasing cervical cancer screening coverage in the middle east an example from lebanon;Draisma, Gerrit  Etzioni, Ruth  Tsodikov, Alex  Mariotto, Angela  Wever, Elisabeth  Gulati, Roman  Feuer, Eric  de Koning, Harry;
Noneg;nahvijou2016.pdf;cost-effectiveness of different cervical screening strategies in islamic republic of iran a middle-income country with a low incidence rate of cervical cancer;Accetta G, Biggeri A, Carreras G, Lippi G, Carozzi FM, Confortini M, Zappa M, Paci E.;
Noneg;nghiem2016.pdf;overtreatment and cost-effectiveness of the see-and-treat strategy for managing cervical precancer;Armstrong EP.;
Noneg;naber2016.pdf;the potential harms of primary human papillomavirus screening in over-screened women a microsimulation study;Dreyfuss, John Henry;
Noneg;cronin2013.pdf;cost-effectiveness of an advance notification letter to increase colorectal cancer screening;Jiang H, Brown PE,,, Walter SD.;
Noneg;frame1998.pdf;determinants of cancer screening frequency the example of screening for cervical cancer;Gogov, D.  Muehlberger, N.  Iskandar, R.  Alimohammadi, Y.  Siebert, U.;
Noneg;medi-95-e3762.pdf;economic evaluation study cheer-compliant cost-effectiveness analysis of ras screening for treatment of metastatic colorectal cancer based on the calgb 80405 trial;Rafia R, Brennan A, Madan J, Collins K, Reed MW, Lawrence G, Robinson T, Greenberg D, Wyld L.;
Noneg;oncotarget-07-48168.pdf;expected long-term impact of screening endoscopy on colorectal cancer incidence a modelling study;van der Meulen, Miriam P.  Lansdorp-Vogelaar, Iris  van Heijningen, Else-Mariette B.  Kuipers, Ernst J.  van Ballegooijen, Marjolein;
Noneg;brenner2015.pdf;expected long-term impact of the german screening colonoscopy programme on colorectal cancer prevention analyses based on 4407971 screening colonoscopies;Price, Stuart  Golden, Bruce  Wasil, Edward  Denton, Brian T.;
Noneg;flores2010.pdf;hpv testing for cervical cancer screening appears more cost-effective than papanicolau cytology in mexico;Seigneurin, Arnaud  Labarere, Joee  Francois, Olivier  Exbrayat, Catherine  Dupouy, Maylis  Filippi, Marc  Colonna, Marc;
Noneg;berhane2003.pdf;Inference in Spline-Based Models for Multiple Time-to-Event Data, with Applications to a Breast Cancer Prevention Trial ;Landoni, Elena, Ambrogi, Federico, Mariani, Luigi, Miceli, Rosalba;
Noneg;meester2018.pdf;optimizing colorectal cancer screening by race and sex microsimulation analysis ii to inform the american cancer society colorectal cancer screening guideline;Van Effelterre TP, Hogea C, Taylor SM.;
Noneg;seppnen2008.pdf;predicting impacts of mass-screening policy changes on breast cancer mortality;Matthijsse SM, Hontelez JA, Naber SK, Rozemeijer K, de Kok IM, Bakker R, van Ballegooijen M, van Rosmalen J, de Vlas SJ.;
Noneg;campbell2016.pdf;understanding the effects of competition for constrained colonoscopy services with the introduction of population-level colorectal cancer screening a discrete event simulation model;Wright, Thomas  Huang, Joice  Baker, Edward  Garfield, Susan  Hertz, Deanna  Cox, J. Thomas;
Noneg;duffy2009.pdf;Use of lung cancer risk models in planning research and service programs in CT screening for lung cancer;Felix, Juan C.  Lacey, Michael J.  Miller, Jeffrey D.  Lenhart, Gregory M.  Spitzer, Mark  Kulkarni, Rucha;
Noneg;loeve2000.pdf;Endoscopic Colorectal Cancer Screening: a Cost-Saving Analysis;Chanthavilay P., Reinharz D., Mayxay M., Phongsavan K., Marsden D.E., Moore L., White L.J.;
Noneg;clries2013.pdf;Predicting the Change in Breast Cancer Deaths in Spain by 2019;Birnbaum J, Gadi VK, Markowitz E, Etzioni R.;
Noneg;subramanian2017.pdf;Personalized medicine for prevention: can risk stratified screening decrease colorectal cancer mortality at an acceptable cost?;Stone CA, May FW, Pinnock CB, Elwood M, Rowett DS.;
Noneg;wang2018.pdf;Challenges and research opportunities for lung cancer screening in China;Velentzis, Louiza S.  Caruana, Michael  Simms, Kate T.  Lew, Jie-Bin  Shi, Ju-Fang  Saville, Marion  Smith, Megan A.  Lord, Sarah J.  Tan, Jeffrey  Bateson, Deborah  Quinn, Michael  Canfell, Karen;
Noneg;10.1177@0272989x17718168.pdf;comparing cisnet breast cancer incidence and mortality predictions to observed clinical trial results of mammography screening from ages 40 to 49;Meester, Reinier G. S.  Doubeni, Chyke A.  Zauber, Ann G.  van Ballegooijen, Marjolein  Corley, Douglas A.  Lansdorp-Vogelaar, Iris;
Noneg;kerlikowske1999.pdf;Continuing screening mammography in women aged 70 to 79 years: impact on life expectancy and cost-effectiveness.;Jacklyn, Gemma  Howard, Kirsten  Irwig, Les  Houssami, Nehmat  Hersch, Jolyn  Barratt, Alexandra;
Noneg;bech2000.pdf;cost implications of routine mammography screening of women 50-69 years in the county of funen denmark;Med J Aust.  Mar .():e-.;
Noneg;ijcp-09-01-5443.pdf;cost-effectiveness of three rounds of mammography breast cancer screening in iranian women;Lew, Jie-Bin  St John, D. James B.  Xu, Xiang-Ming  Greuter, Marjolein J. E.  Caruana, Michael  Cenin, Dayna R.  He, Emily  Saville, Marion  Grogan, Paul  Coupe, Veerle M. H.  Canfell, Karen;
Noneg;arrospide2016.pdf;economic evaluation of the breast cancer screening programme in the basque country retrospective cost-effectiveness and budget impact analysis;Taksler, Glen B., Perzynski, Adam T., Kattan, Michael W.;
Noneg;lew2018.pdf;Evaluation of the benefits, harms and cost-effectiveness of potential alternatives to iFOBT testing for colorectal cancer screening in Australia;Sutradhar R,,, Gu S, Paszat LF,,.;
Noneg;jiang2015.pdf;inference on cancer screening exam accuracy using population-level administrative data;Ten Haaf K, Tammem?gi MC, Bondy SJ,, van der Aalst CM, Gu S, McGregor SE, Nicholas G, de Koning HJ, Paszat LF,.;
Noneg;alagoz2018.pdf;introduction to the cancer intervention and surveillance modeling network cisnet breast cancer models;Subramanian, Sujha, Bobashev, Georgiy, Morris, Robert J., Hoover, Sonja;
Noneg;monsonego2004.pdf;Screening 3 years after negative test, rather than annually, would result in three additional cases of cervical cancer per 100,000 women screened;Chiu, Sherry Yueh-Hsia  Malila, Nea  Yen, Amy Ming-Fang  Chen, Sam Li-Sheng  Fann, Jean Ching-Yuan  Hakama, Matti;
Noneg;sekiguchi2015.pdf;optimal use of colonoscopy and fecal immunochemical test for population-based colorectal cancer screening a cost-effectiveness analysis using japanese data;Coldman, Andrew, Flanagan, William, Nadeau, Claude, Wolfson, Michael, Fitzgerald, Natalie, Memon, Saima, Gauvreau, Cindy, Miller, Anthony, Earle, Craig;
Noneg;campos2017.pdf;the health and economic impact of scaling cervical cancer prevention in 50 low- and lower-middle-income countries;Greuter MJE, de Klerk CM, Meijer GA, Dekker E, Coup?? VMH.;
Noneg;berkowitz2018.pdf;multilevel small-area estimation of colorectal cancer screening in the united states;Goldie SJ, Kohli M, Grima D, Weinstein MC, Wright TC, Bosch FX, Franco E.;
Noneg;idigoras2018.pdf;evaluation of the colorectal cancer screening programme in the basque country spain and its effectiveness based on the miscan-colon model;Berkhof J, de Bruijne MC, Zielinski GD, Meijer CJ.;
Noneg;sonnenberg2002.pdf;cost-effectiveness of a single colonoscopy in screening for colorectal cancer;Castle, Philip E.  Wheeler, Cosette M.  Campos, Nicole G.  Sy, Stephen  Burger, Emily A.  Kim, Jane J.;
Noneg;melnitchouk2018.pdf;cost-effectiveness of colorectal cancer screening in Ukraine;Alagoz, Oguzhan, Berry, Donald A., de Koning, Harry J., Feuer, Eric J., Lee, Sandra J., Plevritis, Sylvia K., Schechter, Clyde B., Stout, Natasha K., Trentham-Dietz, Amy, Mandelblatt, Jeanne S.;
Noneg;zelle2012.pdf;costs effects and cost-effectiveness of breast cancer control in ghana; Pyenson B.S., Tomicki S.M. ;
Noneg;chen1998.pdf;evaluation by markov chain models of a non-randomised breast cancer screening programme in women aged under 50 years in sweden;Berkowitz Z., Zhang X., Richards T.B., Nadel M., Peipins L.A., Holt J.;
Noneg;duffy2010.pdf;Modelling the likely effect of the increase of the upper age limit from 70 to 73 for breast screening in the UK National Programme;Bertsimas, Dimitris  Silberholz, John  Trikalinos, Thomas;
Noneg;goede2017.pdf;harms benefits and costs of fecal immunochemical testing versus guaiac fecal occult blood testing for colorectal cancer screening;Meester, Reinier G. S., Peterse, Elisabeth F. P., Knudsen, Amy B., de Weerdt, Anne C., Chen, Jennifer C., Lietz, Anna P., Dwyer, Andrea, Ahnen, Dennis J., Siegel, Rebecca L., Smith, Robert A., Zauber, Ann G., Lansdorp-Vogelaar, Iris;
Noneg;lane2010.pdf;Interval Fecal Immunochemical Testing in a Colonoscopic Surveillance Program Speeds Detection of Colorectal Neoplasia;Arnold, Matthias  Quante, Anne S.;
Noneg;subramanian2009.pdf;modeling the cost-effectiveness of colorectal cancer screening policy guidance based on patient preferences and compliance;Castanon, Alejandra, Landy, Rebecca, Pesola, Francesca, Windridge, Peter, Sasieni, Peter;
Noneg;tafazzoli2009.pdf;probabilistic cost-effectiveness comparison of screening strategies for colorectal cancer;Yang, Lan  Wang, Jing  Cheng, Juan  Wang, Yuan  Lu, Wenli;
Noneg;rojnik2008.pdf;probabilistic cost-effectiveness modeling of different breast cancer screening policies in slovenia;de Kok, Inge M. C. M.  Korfage, Ida J.  van den Hout, Wilbert B.  Helmerhorst, Theo J. M.  Habbema, J. Dik F.  Essink-Bot, Marie-Louise  van Ballegooijen, Marjolein;
Noneg;sander2016.pdf;the cost-utility of integrated cervical cancer prevention strategies in the ontario setting - can we do better;Kim JJ, Burger EA,, Regan C, Sy S.;
Noneg;tubiana1990.pdf;the natural history of breast cancer implications for a screening strategy;van den Broek, Jeroen J., van Ravesteyn, Nicolien T., Heijnsdijk, Eveline A., de Koning, Harry J.;
Noneg;campos2017 (1).pdf;to expand coverage or increase frequency quantifying the tradeoffs between equity and efficiency facing cervical cancer screening programs in low-resource settings;Lee TH,, Kim W,, Shin J,, Park EC,, Park S,, Kim TH,.;
Noneg;2043.full.pdf;evaluation of breast cancer risk assessment techniques a cost-effectiveness analysis;Chen TH, Yen AM, Wu GH, Chen LS, Chiu YH.;
Noneg;caleffi2009.pdf;a model to optimize public health care and downstage breast cancer in limited-resource populations in southern brazil porto alegre breast health intervention cohort;Editorial,Comment,Bayes Theorem*,Colorectal Neoplasms/diagnosis*,Colorectal Neoplasms/epidemiology*,Decision Support Techniques*,Disease Progression*,Humans,Male,Mass Screening/standards*,Models, Theoretical*,Prostatic Neoplasms/diagnosis*,Uncertainty*;
Noneg;rutter2010.pdf;an evidence-based microsimulation model for colorectal cancer validation and application;Research Support, Non-U.S. Gov't,Adult,Aged,Antineoplastic Protocols,Asian Continental Ancestry Group,Breast Neoplasms/prevention & control*,Breast Neoplasms/therapy,Chemotherapy, Adjuvant/economics,Cost-Benefit Analysis/methods*,Early Detection of Cancer/economics*,Early Detection of Cancer/methods,Female,Health Care Costs*,Hong Kong,Humans,Immunotherapy/economics,Mammography/economics,Markov Chains,Middle Aged,Quality-Adjusted Life Years,Radiotherapy, Adjuvant/economics;
Noneg;crt-2016-525.pdf;strategic distributional cost-effectiveness analysis for improving national cancer screening uptake in cervical cancer a focus on regional inequality in south korea;Sawaya GF, McConnell KJ, Kulasingam SL, Lawson HW, Kerlikowske K, Melnikow J, Lee NC, Gildengorin G, Myers ER, Washington AE.;
Noneg;10.1136@bmj.e670.pdf;Primary screening for human papillomavirus compared with cytology screening for cervical cancer in European settings: costeffectiveness analysis based on a Dutch microsimulation model;Stoykova B, Kuzmanov G, Dowie R.;
Noneg;10.1.1.557.8022.pdf;Colorectal cancer screening with faecal occult blood test within a multiple disease screening programme: an experience from Keelung, Taiwan;Janes H., Pepe M., Kooperberg C., Newcomb P.;
Noneg;10.1371@journal.pmed.1002225.pdf;performance and cost-effectiveness of computed tomography lung cancer screening scenarios in a population-based setting a microsimulation modeling analysis in ontario canada;Kobayashi, T.  Goto, R.  Ito, K.  Mitsumori, K.;
Noneg;10.5694mja15.00912.pdf;impact of hpv sample self-collection for underscreened women in the renewed cervical screening program;de Koning HJ, Draisma G, Fracheboud J, de Bruijn A.;
Noneg;10.1097@grf.0b013e3182823797.pdf;cost-effectiveness of cervical cancer prevention;Lane JM, Chow E, Young GP, Good N, Smith A, Bull J, Sandford J, Morcom J, Bampton PA, Cole SR.;
Noneg;10.1177@0969141316668379.pdf;breast cancer incidence trends in norway and estimates of overdiagnosis;Howard K, Salkeld G, Irwig L, Adelstein BA.;
Noneg;10.1002@sici1099-1751199901@0314@157@@aid-hpm5313.0.co2-u.pdf;economic analysis of outreach assessment clinics in breast screening programmes;Goldwasser, Deborah L.  Kimmel, Marek;
Noneg;10.1016@j.ypmed.2011.06.009.pdf;digital mammography screening weighing reduced mortality against increased overdiagnosis; Monsonego J. ;
Noneg;10.5888@pcd14.160158.pdf;cost-effectiveness analysis of four simulated colorectal cancer screening interventions north carolina;Eur J Cancer.  May.():-.;
Noneg;chen2010.pdf;alexithymia as a screening index for male conscripts with adjustment disorder;;
Noneg;lee2016.pdf;annual combined mammography and tomosynthesis screening is it really cost-effective;;
Noneg;dolan2013.pdf;can streamlined multicriteria decision analysis be used to implement shared decision making for colorectal cancer screening;;
Noneg;whynes2003.pdf;costs of flexible sigmoidoscopy screening for colorectal cancer in the united kingdom;;
Noneg;lai1998.pdf;efficacy of breast-cancer screening for female relatives of breast-cancer-index cases taiwan multicentre cancer screening tamcas;;
Noneg;whynes1998.pdf;faecal occult blood screening for colorectal cancer is it cost-effective;;
Noneg;fisher2010.pdf;faecal occult blood testing in areas of high incidence and mortality the effect of screening the population aged 50 to 59;;
Noneg;berkhof2005.pdf;natural history and screening model for high-risk human papillomavirus infection neoplasia and cervical cancer in the netherlands;;
Noneg;boer1999.pdf;stage distribution at first and repeat examinations in breast cancer screening;;
Noneg;field2013.pdf;the contribution of risk prediction models to early detection of lung cancer;;
Noneg;peterse2018.pdf;the impact of the rising colorectal cancer incidence in young adults on the optimal age to start screening microsimulation analysis i to inform the american cancer society colorectal cancer screening guideline;;
Noneg;chauvin2013.pdf;The influence of waiting times on cost-effectiveness: a case study of colorectal cancer mass screening;;
Noneg;castro2005.pdf;the relation of breast cancer staging to screening protocol compliance a computer simulation study;;
Noneg;bergstrm1999.pdf;trends in cancer of the cervix uteri in sweden following cytological screening;;
Noneg;ramsey2000.pdf;SIMULATION MODELING  OF OUTCOMES AND COST-EFFECTIVENESS ;;
Noneg;mclay2010.pdf;using simulation-optimization to construct screening strategies for cervical cancer;;
Noneg;subramanian2010.pdf;when budgets are tight there are better options than colonoscopies for colorectal cancer screening;;
q12;lgj008.pdf;the spectrum population model of the impact of screening and treatment on us breast cancer trends from 1975 to 2000 principles and practice of the model methods;;
q12;kulasingam2003.pdf;Potential Health and Economic Impact of Adding a Human Papillomavirus Vaccine to Screening Programs;Feuer EJ, Etzioni R, Cronin KA, Mariotto A.;
q12;feuer2004.pdf;The use of modeling to understand the impact of screening on US mortality: examples from mammography and PSA testing;Stout NK, Goldhaber-Fiebert JD, Ortendahl JD, Goldie SJ.;
q12;kulasingam2007.pdf;a cost-effectiveness analysis of adding a human papillomavirus vaccine to the australian national cervical cancer screening program;Siebert, U  Sroczynski, G  Hillemanns, P  Engel, J  Stabenow, R  Stegmaier, C  Voigt, K  Gibis, B  Holzel, D  Goldie, SJ;
q12;rogoza2008.pdf;optimization of primary and secondary cervical cancer prevention strategies in an era of cervical cancer vaccination a multi-regional health economic analysis;Hanin LG, Miller A, Zorin AV, Yakovlev AY.;
q12;dee2009.pdf;a cost-utility analysis of adding a bivalent or quadrivalent hpv vaccine to the irish cervical screening programme;Berkhof, Johannes  Coupe, Veerle M.  Bogaards, Johannes A.  van Kemenade, Folkert J.  Helmerhorst, Theo J.  Snijders, Peter J.  Meijer, Chris J.;
q12;accetta2010.pdf;is human papillomavirus screening preferable to current policies in vaccinated and unvaccinated women a cost-effectiveness analysis;Castro F, Carter KJ, Kessler E, Erickson BA, Kseibi SA.;
q12;canfell2010.pdf;models of cervical screening in the era of human papillomavirus vaccination;Mandelblatt J, Schechter CB, Lawrence W, Yi B, Cullen J.;
q12;obradovic2010.pdf;cost-effectiveness analysis of hpv vaccination alongside cervical cancer screening programme in slovenia;Int J Cancer.  Sep .():-. doi: ./ijc.. Epub  Feb .;
q12;praditsitthikorn2011.pdf;Economic Evaluation of Policy Options for Prevention and Control of Cervical Cancer in Thailand;Loeve, F, Boer, R, van Oortmarssen, GJ, van Ballegooijen, M, Habbema, JDF;
q12;yamamoto2011.pdf;introducing hpv vaccine and scaling up screening procedures to prevent deaths from cervical cancer in japan a cost-effectiveness analysis;Canfell K, Barnabas R, Patnick J, Beral V.;
q12;ladabaum2001.pdf;aspirin as an adjunct to screening for prevention of sporadic colorectal cancer a cost-effectiveness analysis;Tay K, Tay SK.;
q12;carreras2012.pdf;can a national lung cancer screening program in combination with smoking cessation policies cause an early decrease in tobacco deaths in italy;Dig Liver Dis.  Jan.():-. doi: ./j.dld.... Epub  Sep .;
q12;mo2017.pdf;cost-effectiveness analysis of different types of human papillomavirus vaccination combined with a cervical cancer screening program in mainland china;Gulati, Roman  Tsodikov, Alex  Wever, Elisabeth M.  Mariotto, Angela B.  Heijnsdijk, Eveline A. M.  Katcher, Jeffrey  de Koning, Harry J.  Etzioni, Ruth;
q12;thiry2009.pdf;cost-effectiveness of human papillomavirus vaccination in belgium do not forget about cervical cancer screening;Wu D, Kafadar K, Rosner GL, Broemeling LD.;
q12;duffy2016.pdf;the effects of population-based mammography screening starting between age 40 and 50 in the presence of adjuvant systemic therapy;van Ravesteyn NT, Miglioretti DL, Stout NK, Lee SJ, Schechter CB, Buist DS, Huang H, Heijnsdijk EA, Trentham-Dietz A, Alagoz O, Near AM, Kerlikowske K, Nelson HD, Mandelblatt JS, de Koning HJ.;
q12;tay2011.pdf;the impact of cytology screening and hpv vaccination on the burden of cervical cancer;Wever, E. M.  Hugosson, J.  Heijnsdijk, E. A. M.  Bangma, C. H.  Draisma, G.  de Koning, H. J.;
q12;villanti2013.pdf;a cost-utility analysis of lung cancer screening and the additional benefits of incorporating smoking cessation interventions;Malik T, Reimer J, Gumel A, Elbasha EH, Mahmud S.;
q12;kivutibitok2014.pdf;system dynamics model of cervical cancer vaccination and screening interventions in kenya;J Natl Cancer Inst Monogr. .():-.;
q12;diaz2010.pdf;cost-effectiveness of human papillomavirus vaccination and screening in spain;Chauvin P, Josselin JM, Heresbach D.;
q12;janes2005.pdf;identifying target populations for screening or not screening using logic regression;Korostil I.A., Regan D.G.;
q12;bradley2011.pdf;Productivity Savings from Colorectal Cancer Prevention and Control Strategies;Burger EA, Kim JJ.;
q12;mandelblatt2013.pdf;which strategies reduce breast cancer mortality most;Duffy SW, Field JK, Allgood PC, Seigneurin A.;
q12;steens2012.pdf;association between human papillomavirus vaccine uptake and cervical cancer screening in the netherlands implications for future impact on prevention;Hestbech, Mie Sara  Lynge, Elsebeth  Kragstrup, Jakob  Siersma, Volkert  Baillet, Miguel Vazquez-Prada  Brodersen, John;
q12;zimmermann2017.pdf;cost-effectiveness of cervical cancer screening and preventative cryotherapy at anHIV treatment clinic in Kenya;O'Mahony JF,, van Rosmalen J,, Mushkudiani NA, Goudsmit FW, Eijkemans MJ, Heijnsdijk EA, Steyerberg EW, Habbema JD.;
q12;10.1.1.552.8587.pdf;evolution of multiple disease screening in keelung a model for community involvement in health interventions;Muehlberger, Nikolai  Kurzthaler, Christina  Iskandar, Rowan  Krahn, Murray D.  Bremner, Karen E.  Oberaigner, Willi  Klocker, Helmut  Horninger, Wolfgang  Conrads-Frank, Annette  Sroczynski, Gaby  Siebert, Uwe;
q12;lefevere2011.pdf;like mother like daughter mothers history of cervical cancer screening and daughters human papillomavirus vaccine uptake in flanders belgium;Matthijsse SM, van Rosmalen J, Hontelez JA, Bakker R, de Kok IM, van Ballegooijen M, de Vlas SJ.;
q12;canfell2011.pdf;prevention of cervical cancer in rural china evaluation of hpv vaccination and primary hpv screening strategies;Fitch, Kathryn, Pyenson, Bruce, Blumen, Helen, Weisman, Thomas, Small, Art;
q12;sharma2015.pdf;The value of male human papillomavirus vaccination in preventing cervical cancer and genital warts in a low-resource setting;van Ravesteyn, Nicolien T.  van Lier, Lisanne  Schechter, Clyde B.  Ekwueme, Donatus U.  Royalty, Janet  Miller, Jacqueline W.  Near, Aimee M.  Cronin, Kathleen A.  Heijnsdijk, Eveline A. M.  Mandelblatt, Jeanne S.  de Koning, Harry J.;
q12;taksler2016.pdf;modeling individual patient preferences for colorectal cancer screening based on their tolerance for complications risk;Eur J Gen Pract.  Dec.():-. doi: ./... Epub  Aug .;
q12;wever2011.pdf;how does early detection by screening affect disease progression modeling estimated benefits in prostate cancer screening;Naber SK, de Kok IM, Matthijsse SM, van Ballegooijen M.;
q12;mccann2004.pdf;Modelling the impact of detecting and treating carcinoma in situ in a breast screening programme;van Luijt, Paula A.  Rozemeijer, Kirsten  Naber, Steffie K.  Heijnsdijk, Eveline A. M.  van Rosmalen, Joost  van Ballegooijen, Marjolein  de Koning, Harry J.;
q12;10.1177@0272989x17711928.pdf;simulating the impact of risk-based screening and treatment on breast cancer outcomes with miscan-fadia;Sharma M., Sy S., Kim J.J.;
q12;birnbaum2016.pdf;the effect of treatment advances on the mortality results of breast cancer screening trials a microsimulation model;Luttjeboer J, Setiawan D, Cao Q, Cahh Daemen T, Postma MJ.;
q12;beaber2015.pdf;Unifying Screening Processes Within the PROSPR Consortium: A Conceptual Model for Breast, Cervical,and Colorectal Cancer Screening;Smith, Megan A.  Gertig, Dorota  Hall, Michaela  Simms, Kate  Lew, Jie-Bin  Malloy, Michael  Saville, Marion  Canfell, Karen;
q12;guerrero2015.pdf;a cost-utility analysis of cervical cancer screening and human papillomavirus vaccination in the philippines;Int J Gynaecol Obstet.  Jul. Suppl :-. doi: ./ijgo..;
q12;lin2011.pdf;comparing the benefits of screening for breast cancer and lung cancer using a novel natural history model;Han, Summer S.  ten Haaf, Kevin  Hazelton, William D.  Munshi, Vidit N.  Jeon, Jihyoun  Erdogan, Saadet A.  Johanson, Colden  McMahon, Pamela M.  Meza, Rafael  Kong, Chung Yin  Feuer, Eric J.  de Koning, Harry J.  Plevritis, Sylvia K.;
q12;birnbaum2018.pdf;early detection and treatment strategies for breast cancer in low-income and upper middle-income countries a modelling study;Schiller-Fruehwirth, Irmgard  Jahn, Beate  Einzinger, Patrick  Zauner, Guenther  Urach, Christoph  Siebert, Uwe;
q12;sinanovic2009.pdf;the potential cost-effectiveness of adding a human papillomavirus vaccine to the cervical cancer screening programme in south africa;Campos NG, Tsu V, Jeronimo J, Mvundura M, Lee K,, Kim JJ.;
q12;sopina2011.pdf;cost-effectiveness of a cervical screening program with human papillomavirus vaccine;Peterse, Elisabeth F. P., Meester, Reinier G. S., Siegel, Rebecca L., Chen, Jennifer C., Dwyer, Andrea, Ahnen, Dennis J., Smith, Robert A., Zauber, Ann G., Lansdorp-Vogelaar, Iris;
q12;hkm1512sp6p9.pdf;generalised cost-effectiveness analysis for breast cancer prevention and care in hong kong chinese;Sinanovic E, Moodley J, Barone MA, Mall S, Cleary S, Harries J.;
q12;158.full.pdf;effect of time to diagnostic testing for breast cervical and colorectal cancer screening abnormalities on screening efficacy a modeling study;Int J Radiat Oncol Biol Phys.  Nov.():-.;
q12;hoerger2011.pdf;Estimated Effects of the National Breast and Cervical Cancer Early Detection Program on Breast Cancer Mortality;;
